Processing 00000000.tx.1: Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease Jean-Charles Lambert, Claudine Berr1, Florence Pasquier2, Andr Delacourte3, Bernard Frigard4, Dominique Cottel, Jordi Prez-Tur5, Vincent Mouroux, Michel Mohr6, Danielle Ccyre7, Douglas Galasko8, Corinne Lendon9, Judes Poirier7, John Hardy5, David Mann10, Philippe Amouyel and Marie-Christine Chartier-Harlin* INSERM CJF95-05, Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP 245, 59019 Lille Cdex, France, 1INSERM U360, Hpital de la Salptrire, 75651 Paris Cdex 13, France, 2CHR et U de Lille, Clinique Neurologique, Centre de la Mmoire, Hpital Salengro, 59037 Lille Cdex, France, 3INSERM U422, Place de Verdun, 59045 Lille Cdex, France, 4Centre de Griatrie de Wasquehal, rue Salvador Allende, BP 165, 59444 Wasquehal, France, 5Birdsall Building, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA, 6Institut de Pathologie, 1 place de l'Hpital, BP 22, 67064 Strasbourg Cdex, France, 7McGill Centre for Studies in Aging, 6875 La Salle Boulevard, Verdun, Qubec, Canada H4H 1R3, 8Department of Neurosciences, University of California, San Diego, 3350 La Jolla Village Drive, San Diego, CA 9216, USA, 9Departments of Psychiatry, Neurology and Genetics, Washington University School of Medicine, St Louis, MO 63310, USA and 10Department of Pathological Sciences, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT, UK Received June 1, 1998 Revised and Accepted July 8, 1998 Possession of the apolipoprotein E (APOE) [epsis]4 allele is the most frequently associated genetic susceptibility factor for Alzheimer's disease (AD). 

Phrase: "Pronounced impact of Th1/E47cs mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "compared with -491"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "AT mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on neural APOE gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0017262:Gene Expression [Genetic Function]
   861   C1412481:APOE gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "risk of developing Alzheimer's disease Jean-Charles Lambert,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1281905:disease risk [Finding]
   744   C0035647:Risk [Qualitative Concept]

Phrase: "Claudine Berr1,"

Phrase: "Florence Pasquier2,"

Phrase: "Andr Delacourte3,"

Phrase: "Bernard Frigard4,"

Phrase: "Dominique Cottel,"

Phrase: "Jordi Prez-Tur5,"

Phrase: "Vincent Mouroux,"

Phrase: "Michel Mohr6,"

Phrase: "Danielle Ccyre7,"

Phrase: "Douglas Galasko8,"

Phrase: "Corinne Lendon9,"

Phrase: "Judes Poirier7,"

Phrase: "John Hardy5,"

Phrase: "David Mann10,"

Phrase: "Philippe Amouyel"

Phrase: "and"

Phrase: "Marie-Christine Chartier-Harlin"

Phrase: "* INSERM CJF95-05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C0023031:La [Element, Ion, or Isotope]
   788   C3245503:national [Intellectual Product]

Phrase: "Institut Pasteur de Lille,"

Phrase: "1 rue du Professeur Calmette,"

Phrase: "BP 245,"

Phrase: "59019 Lille Cdex,"

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "1INSERM U360,"

Phrase: "Hpital de la Salptrire,"

Phrase: "75651 Paris Cdex 13,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0030561:Paris [Geographic Area]
   812   C0331677:Paris [Plant]
   812   C1824032:PARIS [Gene or Genome]
   779 E C1824369:PARI [Gene or Genome]

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "2CHR et U de Lille,"

Phrase: "Clinique Neurologique,"

Phrase: "Centre de la Mmoire,"

Phrase: "Hpital Salengro,"

Phrase: "59037 Lille Cdex,"

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "3INSERM U422,"

Phrase: "Place de Verdun,"

Phrase: "59045 Lille Cdex,"

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "4Centre de Griatrie de Wasquehal,"

Phrase: "rue Salvador Allende,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2760314:Allende [Eukaryote]

Phrase: "BP 165,"

Phrase: "59444 Wasquehal,"

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "5Birdsall Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547706:Building [Functional Concept]
   861   C1999269:Building [Manufactured Object]

Phrase: "Mayo Clinic Jacksonville,"

Phrase: "4500 San Pablo Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442650:Road [Manufactured Object]

Phrase: "Jacksonville,"

Phrase: "FL 32224,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "6Institut de Pathologie,"

Phrase: "1 place de l'Hpital,"

Phrase: "BP 22,"

Phrase: "67064 Strasbourg Cdex,"

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "7McGill Centre for Studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "in Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "6875 La Salle Boulevard,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0683904:boulevard [Manufactured Object]

Phrase: "Verdun,"

Phrase: "Qubec,"

Phrase: "Canada H4H 1R3,"

Phrase: "8Department of Neurosciences,"

Phrase: "University of California,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006754:California [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C3146274:California [Plant]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "3350 La Jolla Village Drive,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0013126:Drive [Mental Process]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA 9216,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "9Departments of Psychiatry,"

Phrase: "Neurology"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "and"

Phrase: "Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "Washington University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO 63310,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "10Department of Pathological Sciences,"

Phrase: "Stopford Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547706:Building [Functional Concept]
   861   C1999269:Building [Manufactured Object]

Phrase: "University of Manchester,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Oxford Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442650:Road [Manufactured Object]

Phrase: "Manchester M13 9PT,"

Phrase: "UK"

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "June 1,"

Phrase: "1998"

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted July 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1998 Possession of the apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0871103:possession [Quantitative Concept]

Phrase: "(APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: ")"

Phrase: "[epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "the most frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332183:Frequently [Temporal Concept]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "genetic susceptibility factor for Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0679238:disease factor [Functional Concept]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "(AD"

Phrase: ")."
Processing 00000000.tx.2: Recently, new polymorphisms in the regulatory region of the APOE gene have been described. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "new polymorphisms in the regulatory region of the APOE gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C0678951:gene polymorphisms [Genetic Function]
   739   C0032529:polymorphisms [Genetic Function]
   706 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.3: We analysed the effects of three of these mutations (-491 AT, -427 CT and Th1/E47cs) on disease risk in a large case-control study, and tested their impacts on APOE allelic expression in brain tissues. 

Phrase: "We"

Phrase: "analysed"

Phrase: "the effects of three of these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "(-491 AT, -"

Phrase: "427 CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "Th1/E47cs"

Phrase: ")"

Phrase: "on disease risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1281905:disease risk [Finding]
   861   C0035647:Risk [Qualitative Concept]

Phrase: "in a large case-control study,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   923   C0007328:Case-Control Study [Research Activity]
   875   C0085973:Case Study [Intellectual Product]
   861   C0872128:case control [Health Care Activity]
   812   C0243148:control [Qualitative Concept]
   812   C0557651:Study [Manufactured Object]
   812   C0868928:Case [Functional Concept]
   812   C1550141:Control [Substance]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C2603343:Study [Research Activity]
   812   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "their impacts on APOE allelic expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1825598:IMPACT [Gene or Genome]

Phrase: "in brain tissues."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0440746:brain tissues [Tissue]
   966 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissues [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.4: The Th1/E47cs T allele was associated with an increased risk of occurrence of AD, while the -491 T allele was associated with a decreased risk, independently of the APOE [epsis]2/[epsis]3/[epsis]4 polymorphism effect. 

Phrase: "The Th1/E47cs T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "associated with an increased risk of occurrence of AD,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0035647:Risk [Qualitative Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0243132:occurrence [Functional Concept]
   742   C0442805:Increased [Functional Concept]
   742   C1554210:occurrence [Idea or Concept]
   742   C2745955:Occurrence [Temporal Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "while"

Phrase: "the -491 T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "associated with a decreased risk,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "independently of the APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 polymorphism effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.5: However, the impact of the Th1/E47cs mutation was the strongest. 

Phrase: "However,"

Phrase: "the impact of the Th1/E47cs mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1825598:IMPACT [Gene or Genome]

Phrase: "was"

Phrase: "the strongest."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   966   C0442821:Strong [Qualitative Concept]
   916 E C0237897:Strength [Quantitative Concept]
   916 E C0808080:Strength [Idea or Concept]
   916 E C1705922:Strength [Qualitative Concept]
Processing 00000000.tx.6: The -427 CT polymorphism was not associated with the disease. 

Phrase: "The -427 CT polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with the disease."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.7: In AD subjects heterozygous for the [epsis]4 allele, analysis of allelic expression showed that the relative expression levels of the [epsis]4 allele were higher than those of the corresponding controls. 

Phrase: "In AD"

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "heterozygous for the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygous [Organism Attribute]

Phrase: "]4 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "analysis of allelic expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the relative expression levels of the [epsis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Levels [Qualitative Concept]
   745   C3244092:expression level [Idea or Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "were"

Phrase: "higher than those of the corresponding controls."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.8: Consistent with epidemiological data, the relative level of expression of the [epsis]4 allele was modified accordingly to the presence or absence of the two main promoter polymorphisms, indicating, in vivo, the deleterious effect of the Th1/E47cs T allele and the protective effect of the -491 T allele in population. 

Phrase: "Consistent with epidemiological data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the relative level of expression of the [epsis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C3244092:expression level [Idea or Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "accordingly to the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "absence of the two main promoter polymorphisms,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "indicating"

Phrase: ","

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the deleterious effect of the Th1/E47cs T allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "the protective effect of the -491 T allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "in population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.9: These data indicate that in addition to the qualitative effect of the APOE [epsis]2/[epsis]3/[epsis]4 polymorphisms on the AD occurrence, the quantitative variation of expression of these alleles due to functional APOE promoter mutations, is a key determinant of AD development. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that in addition to the qualitative effect of the APOE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205556:Qualitative [Qualitative Concept]
   739   C0523511:APOE [Laboratory Procedure]
   739   C1280500:Effect [Qualitative Concept]
   739   C1412481:APOE [Gene or Genome]
   739   C1883712:Addition [Functional Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 polymorphisms on the AD occurrence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "the quantitative variation of expression of these alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variation [Qualitative Concept]

Phrase: "due to functional APOE promoter mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "a key determinant of AD development."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.10: INTRODUCTION The presence of at least one apolipoprotein E (APOE) [epsis]4 allele is a major genetic susceptibility factor for late-onset familial and sporadic Alzheimer's disease (AD). 

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "The presence of"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "at least one apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: ")"

Phrase: "[epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "a major genetic susceptibility factor for late-onset familial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   762   C0960756:factor A [Organic Chemical]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "sporadic Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")."
Processing 00000000.tx.11: This risk factor accounts for ~45-60% of cases (1). 

Phrase: "This risk factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035648:Risk factor [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "accounts for ~45-60% of cases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: Indeed, the [epsis]4 allele is associated with an increased risk of AD in an allele dose dependant manner (2,3). 

Phrase: "Indeed,"

Phrase: "the [epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "associated with an increased risk of AD"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0035647:Risk [Qualitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in an allele dose dependant manner"

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Conversely, the [epsis]2 allele protects against the disease (4,5). 

Phrase: "Conversely,"

Phrase: "the [epsis"

Phrase: "]2 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "protects against the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.14: The mechanisms by which apoE isoforms are implicated in human nervous system physiology and influence the pathogenesis of AD, are not fully understood (2,6-8). 

Phrase: "The mechanisms by which apoE isoforms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "implicated in human nervous system physiology"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0027767:Nervous System Physiology [Organ or Tissue Function]
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0031842:Physiology [Biomedical Occupation or Discipline]
   753   C0031843:physiology [Physiologic Function]
   753   C0086418:Human [Human]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   734 E C0205494:Neurologic [Qualitative Concept]

Phrase: "and"

Phrase: "influence"

Phrase: "the pathogenesis of AD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]

Phrase: "are"

Phrase: "not fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6-8"

Phrase: ")."
Processing 00000000.tx.15: The effect of the APOE [epsis]2/[epsis]3/[epsis]4 alleles may not be due only to the intrinsic biochemical properties of the isoforms coded by these alleles. 

Phrase: "The effect of the APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "due only to the intrinsic biochemical properties of the isoforms"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   757   C0678226:Due to [Functional Concept]
           due
   739   C0205102:Intrinsic [Spatial Concept]
   739   C0205171:Only [Quantitative Concept]
   739   C0205474:Biochemical [Functional Concept]
   739   C0439674:Intrinsic [Functional Concept]
   739   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   739   C0871161:properties [Qualitative Concept]
   739   C1292721:properties [Functional Concept]
   739   C1720467:Only [Intellectual Product]
   739   C3146286:Due [Idea or Concept]
   706 E C1882134:Property [Conceptual Entity]
   706 E C2347695:Property [Entity]

Phrase: "coded by these alleles."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002085:Alleles [Gene or Genome]
   737   C0009219:code [Occupational Activity]
   737   C0805701:Code [Intellectual Product]
Processing 00000000.tx.16: Other genetic variants influencing APOE allele expression may account for the increase or decrease in the level of risk of AD. 

Phrase: "Other genetic variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "influencing"

Phrase: "APOE allele expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "account for the increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442805:Increase [Functional Concept]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "or"

Phrase: "decrease in the level of risk of AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.17: This hypothesis is supported firstly by preliminary observations of the relative overexpression of the [epsis]4 allele compared with the [epsis]3 allele in the brain of patients with AD, compared with controls (9). 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "firstly by preliminary observations of the relative overexpression of the [epsis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   738   C0080103:Relative [Family Group]
   738   C0205345:Relative [Qualitative Concept]
   738   C0302523:observations [Research Activity]
   738   C0439611:Preliminary [Temporal Concept]
   738   C0700325:observations [Health Care Activity]
   738   C1279901:Firstly [Qualitative Concept]
   738   C1514559:Overexpression [Genetic Function]
   738   C1547039:*Relative [Quantitative Concept]
   738   C3244290:observations [Functional Concept]
   704 E C1964257:Observation [Diagnostic Procedure]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "compared with the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "]3 allele in the brain of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Allele [Gene or Genome]

Phrase: "with AD,"

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.18: Secondly, Th1/E47cs and -491 AT polymorphisms located in the APOE promoter have been described and associated with AD risk (10,11). 

Phrase: "Secondly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205436:Secondly [Quantitative Concept]

Phrase: "Th1/E47cs"

Phrase: "and -"

Phrase: "491 AT polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0032529:polymorphisms [Genetic Function]
   756 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "located in the APOE promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "associated with AD risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035647:Risk [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(10,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.19: Moreover the effect of these two polymorphisms on AD occurrence was described separately in case-control studies. 

Phrase: "Moreover"

Phrase: "the effect of these two polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on AD occurrence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243132:occurrence [Functional Concept]
   861   C1554210:occurrence [Idea or Concept]
   861   C2745955:Occurrence [Temporal Concept]

Phrase: "was"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "separately in case-control studies."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   862   C0007328:Case-Control Studies [Research Activity]
   806   C0872128:case control [Health Care Activity]
   797   C0085973:Case Studies [Intellectual Product]
   760   C0243148:control [Qualitative Concept]
   760   C0868928:Case [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1550141:Control [Substance]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.20: This prompted us to analyse the relative contribution of these two promoter polymorphisms, and also a third, located at position -427 of the APOE promoter together with the [epsis]2/[epsis]3/[epsis]4 alleles, towards AD risk in a large case-control study (509 controls and 573 AD cases). 

Phrase: "This prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyse"

Phrase: "the relative contribution of these two promoter polymorphisms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "also"

Phrase: "a third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "located at position -427 of the APOE promoter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0523511:APOE [Laboratory Procedure]
   744   C0733755:Position [Spatial Concept]
   744   C1412481:APOE [Gene or Genome]

Phrase: "together with the [epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "towards AD risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "in a large case-control study"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   923   C0007328:Case-Control Study [Research Activity]
   875   C0085973:Case Study [Intellectual Product]
   861   C0872128:case control [Health Care Activity]
   812   C0243148:control [Qualitative Concept]
   812   C0557651:Study [Manufactured Object]
   812   C0868928:Case [Functional Concept]
   812   C1550141:Control [Substance]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C2603343:Study [Research Activity]
   812   C3274648:Control [Qualitative Concept]

Phrase: "(509 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "573 AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.21: Furthermore, we investigated the possible influences of the two main polymorphisms on APOE [epsis]2/[epsis]3/[epsis]4 allelic relative expression in brain tissues, to approach their in vivo functionality, in brain samples from 49 AD cases and 45 controls. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the possible influences of the two main polymorphisms"

Phrase: "on APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 allelic relative expression in brain tissues,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "their in vivo functionality,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   755   C0205245:Functional [Functional Concept]
   755   C0542341:Functional [Functional Concept]
   755   C2700217:Functional [Conceptual Entity]
   734   C1515655:In Vivo [Spatial Concept]
   727 E C0031843:function [Physiologic Function]
   727 E C0700205:FUNCTION [Classification]
   727 E C1705273:Function [Intellectual Product]

Phrase: "in brain samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "from 49 AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "45 controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.22: RESULTS As expected, possession of the [epsis]4 allele was strongly associated with AD [odds ratio (OR) = 5.40; 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "possession of the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0871103:possession [Quantitative Concept]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "strongly"

Phrase: "associated with AD [odds ratio (OR)"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0028873:Odds Ratio [Quantitative Concept]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "= 5.40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439084:>5 [Quantitative Concept]
   861   C0439509:/40 [Temporal Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.23: 95% confidence interval (CI): 4.11-7.09, P < 0.0001], while the presence of the [epsis]2 allele exhibited a protective effect (OR = 0.47; 

Phrase: "95% confidence interval (CI)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "4.11-7.09,"

Phrase: "P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "],"

Phrase: "while"

Phrase: "the presence of the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "]2 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a protective effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 0.47"

Phrase: ";"
Processing 00000000.tx.24: 95% CI: 0.31-0.70, P = 0.0003). 

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.31-0.70,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450355:31 [Intellectual Product]

Phrase: "P = 0.0003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.25: The frequency of the Th1/E47cs T allele was increased in AD cases compared with controls ([chi]2 = 23.1, P < 0.0001; Table 1). 

Phrase: "The frequency of the Th1/E47cs T allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0017270:Allele Frequency [Quantitative Concept]
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1705502:Frequency [Quantitative Concept]

Phrase: "was"

Phrase: "increased in AD cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "[chi]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1720589:Chi [Intellectual Product]

Phrase: "= 23.1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.26: The risk of developing AD for carriers of at least one T allele was 2.13 (95% CI: 1.61-2.83). 

Phrase: "The risk of developing AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "for carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0007294:carriers [Finding]
   966 E C0560175:Carrier [Finding]
   966 E C1706209:Carrier [Medical Device]
   966 E C3273162:Carrier [Intellectual Product]

Phrase: "of"

Phrase: "at least one T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "2.13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.61-2.83"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0580272:1/2 [Intellectual Product]
   875   C1519043:1-2 [Research Activity]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.27: Conversely, the frequency of the -491 T allele was decreased in patients, compared with controls ([chi]2 = 9.5, P = 0.002). 

Phrase: "Conversely,"

Phrase: "the frequency of the -491 T allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0017270:Allele Frequency [Quantitative Concept]
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "was"

Phrase: "decreased in patients,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "[chi]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1720589:Chi [Intellectual Product]

Phrase: "= 9.5,"

Phrase: "P = 0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.28: The genotype and allele frequencies of the -491 AT polymorphism were both similar to those observed in the North American population but differed from the Spanish sample (11). 

Phrase: "The genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "allele frequencies of the -491"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   806   C0017270:Frequencies, Allele [Quantitative Concept]
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "AT polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "both similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "observed in the North American population"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0425358:NORTH AMERICAN [Finding]
   790   C2700615:North American [Population Group]
   753   C0032659:Population [Quantitative Concept]
   753   C0596070:American [Population Group]
   753   C1257890:Population [Population Group]
   753   C1441672:Observed [Functional Concept]
   753   C1709269:North [Spatial Concept]

Phrase: "but"

Phrase: "differed from the Spanish sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086409:SPANISH [Population Group]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]
   760   C3161473:Spanish [Population Group]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.29: The OR to develop AD in subjects bearing at least one -491 T allele was 0.67 (95% CI: 0.52-0.88, P = 0.004). 

Phrase: "The OR to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "develop"

Phrase: "AD in subjects"

Phrase: "bearing at least one -491 T allele"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0002085:Allele [Gene or Genome]
   748   C0205447:One [Quantitative Concept]
   748   C1704689:Bearing [Medical Device]
   714 E C0004897:Bear [Mammal]

Phrase: "was"

Phrase: "0.67"

Phrase: "(95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.52-0.88,"

Phrase: "P = 0.004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.30: No association with the disease was detected for the -427 CT polymorphism. 

Phrase: "No association with the disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1511978:Disease Association [Temporal Concept]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "detected for the -427 CT polymorphism."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0032529:Polymorphism [Genetic Function]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1882417:Polymorphism [Qualitative Concept]
   753   C3540513:CT [Gene or Genome]
Processing 00000000.tx.31: To eliminate possible confounding effects of the APOE [epsis]4 allele on the association of the Th1/E47cs and -491 AT polymorphisms with AD, we controlled the effects of each allele using logistic regression adjusted for the presence or absence of the [epsis]4 allele. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "eliminate"

Phrase: "possible confounding effects of the APOE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "[epsis"

Phrase: "]4 allele on the association of the Th1/E47cs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Allele [Gene or Genome]

Phrase: "and -"

Phrase: "491 AT polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0032529:polymorphisms [Genetic Function]
   756 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "with AD,"

Phrase: "we"

Phrase: "controlled"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "the effects of each allele"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "logistic regression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206031:Logistic Regression [Research Activity]
   861   C0242415:logistic [Occupational Activity]
   861   C0684320:Regression [Pathologic Function]
   861   C0684321:Regression [Mental Process]

Phrase: "adjusted for the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C0456081:Adjusted [Functional Concept]

Phrase: "or"

Phrase: "absence of the [epsis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "]4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.32: After adjustment, the risk associated with possession of at least one Th1/E47cs T allele persisted (OR = 1.56; 

Phrase: "After adjustment,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376209:Adjustment [Individual Behavior]
  1000   C0456081:Adjustment [Functional Concept]
  1000   C0683269:adjustment [Individual Behavior]

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "associated with possession of"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0871103:possession [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "at least one Th1/E47cs T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0002085:Allele [Gene or Genome]

Phrase: "persisted"

Phrase: "(OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 1.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.33: 95% CI: 1.15-2.11, P = 0.004), while the risk associated with -491 T allele did not (OR = 0.82; 

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.15-2.11,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0580272:1/2 [Intellectual Product]
   875   C1519043:1-2 [Research Activity]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "P = 0.004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "associated with -491 T allele"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0002085:Allele [Gene or Genome]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "did"

Phrase: "not (OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "= 0.82"

Phrase: ";"
Processing 00000000.tx.34: 95% CI: 0.62-1.10, P = 0.19). 

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.62-1.10,"

Phrase: "P = 0.19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.35: This observation suggested that the effect of the Th1/E47cs T allele is independent of that of the [epsis]4 allele, while the -491 T allele is not. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the effect of the Th1/E47cs T allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "is independent of that of the [epsis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332291:Independent of [Functional Concept]
   748   C0085862:Independent [Idea or Concept]
   748   C1299583:Independent [Finding]

Phrase: "]4 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "while"

Phrase: "the -491 T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.36: However, since the Th1/E47cs G and [epsis]2 alleles are in complete disequilibrium (Table 2), we also performed a logistic regression including both protective and deleterious effects of [epsis]2 and [epsis]4 alleles, respectively. 

Phrase: "However,"

Phrase: "since"

Phrase: "the Th1/E47cs G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "and ["

Phrase: "epsis"

Phrase: "]2 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "are in complete disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205197:Complete [Qualitative Concept]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C0725685:COMPLEAT [Food]
   770   C1551058:Are [Quantitative Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we also"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a logistic regression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206031:Logistic Regression [Research Activity]
   861   C0242415:logistic [Occupational Activity]
   861   C0684320:Regression [Pathologic Function]
   861   C0684321:Regression [Mental Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "both protective"

Phrase: "and"

Phrase: "deleterious effects of [epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and ["

Phrase: "epsis"

Phrase: "]4 alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.37: The risk associated with the Th1/E47cs T allele still persisted (OR = 1.41; 

Phrase: "The risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "associated with the Th1/E47cs T allele still"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0002085:Allele [Gene or Genome]
   744   C1423842:TH1 [Gene or Genome]
   744   C3540579:TH1 [Gene or Genome]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "persisted"

Phrase: "(OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 1.41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.38: 95% CI: 1.03-1.92, P = 0.03). 

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.03-1.92,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "P = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.39: If we assume that the level of expression of the APOE alleles is increased or decreased due to cis mutations in the promoter region, this hypothesis has two major implications: (i) promoter mutations may modulate the expression of the APOE alleles leading to an increase or decrease of the deleterious or protective risk associated with the [epsis]4 or [epsis]2 allele, respectively; 

Phrase: "If"

Phrase: "we"

Phrase: "assume"

Phrase: "that"

Phrase: "the level of expression of the APOE alleles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C3244092:expression level [Idea or Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "or"

Phrase: "decreased due to cis mutations"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0026882:Mutations [Genetic Function]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C1504308:Cis [Eukaryote]
   760   C3146286:Due [Idea or Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the promoter region,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "has"

Phrase: "two major implications: (i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205164:Major [Qualitative Concept]
   827   C0205448:Two [Quantitative Concept]

Phrase: "promoter mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the expression of the APOE alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leading to an increase"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0332152:Leading [Temporal Concept]
   770   C0442805:Increase [Functional Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "decrease of the deleterious"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "or"

Phrase: "protective risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "associated with the [epsis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "]4 or [epsis"

Phrase: "]2 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "respectively"

Phrase: ";"
Processing 00000000.tx.40: and (ii) given that what determines the risk is the importance of the relative level of expression of both alleles of APOE, as suggested by preliminary data (12), the promoter mutations will have differential effects detectable mainly in APOE [epsis]2/[epsis]3/[epsis]4 heterozygous individuals. 

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "what"

Phrase: "determines"

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "is"

Phrase: "the importance of the relative level of expression of both alleles of APOE,"

Phrase: "as"

Phrase: "suggested by preliminary data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439611:Preliminary [Temporal Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   737   C1705535:Suggest [Idea or Concept]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "the promoter mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "will"

Phrase: "have"

Phrase: "differential effects detectable mainly in APOE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 heterozygous individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]
Processing 00000000.tx.41: To verify these assumptions, we studied the OR of developing AD for APOE heterozygous and homozygous individuals, using logistic regression adjusted for age, sex and the presence of at least one -491 T and one Th1/E47 T allele. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "these assumptions,"

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the OR of developing AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "for APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "and"

Phrase: "homozygous individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "logistic regression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206031:Logistic Regression [Research Activity]
   861   C0242415:logistic [Occupational Activity]
   861   C0684320:Regression [Pathologic Function]
   861   C0684321:Regression [Mental Process]

Phrase: "adjusted for age,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C0456081:Adjusted [Functional Concept]

Phrase: "sex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "the presence of"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "at least one -491 T"

Phrase: "and"

Phrase: "one Th1/E47 T allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.42: In APOE [epsis]2/[epsis]3/[epsis]4 homozygotes, no effect was found (OR = 1.13; 

Phrase: "In APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 homozygotes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "(OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 1.13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.43: 95% CI: 0.77-1.65, and OR = 0.99; 

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.77-1.65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450385:65 [Intellectual Product]

Phrase: "and"

Phrase: "OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 0.99"

Phrase: ";"
Processing 00000000.tx.44: 95% CI: 0.68-1.44, for Th1/E47 T and -491 T alleles, respectively). 

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.68-1.44,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450387:68 [Intellectual Product]

Phrase: "for Th1/E47 T"

Phrase: "and -"

Phrase: "491 T alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.45: Conversely, in APOE [epsis]2/[epsis]3/[epsis]4 heterozygotes, individuals bearing at least one Th1/E47 T allele had an increased risk of developing AD (OR = 3.57; 

Phrase: "Conversely,"

Phrase: "in APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 heterozygotes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019425:Heterozygotes [Organism Attribute]

Phrase: "individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "bearing at least one Th1/E47 T allele"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0002085:Allele [Gene or Genome]
   744   C0205447:One [Quantitative Concept]
   744   C1336596:E47 [Gene or Genome]
   744   C1423842:TH1 [Gene or Genome]
   744   C1704689:Bearing [Medical Device]
   744   C3540579:TH1 [Gene or Genome]
   711 E C0004897:Bear [Mammal]

Phrase: "had"

Phrase: "an increased risk of developing AD (OR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0028873:Risk Ratio [Quantitative Concept]
   767   C0242492:risk ratio [Quantitative Concept]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]

Phrase: "= 3.57"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ";"
Processing 00000000.tx.46: 95% CI: 2.22-5.75, P < 0.0001), while individuals bearing at least one -491 T allele exhibited a protective effect (OR = 0.57; 

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "2.22-5.75,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0450346:2 5 [Quantitative Concept]
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "bearing at least one -491 T allele"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0002085:Allele [Gene or Genome]
   748   C0205447:One [Quantitative Concept]
   748   C1704689:Bearing [Medical Device]
   714 E C0004897:Bear [Mammal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a protective effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 0.57"

Phrase: ";"
Processing 00000000.tx.47: 95% CI: 0.37-0.90, P = 0.014), consistent with our initial hypothesis. 

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.37-0.90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "P = 0.014"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450302:0.014" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "consistent with our initial hypothesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.48: Table 1. 

Phrase: "Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.49: APOE, Th1/E47cs and -491 AT allele and genotype distributions  Allele Genotype APOE [epsis]2 [epsis]3 [epsis]4 [epsis]2[epsis]2a [epsis]2[epsis]3 [epsis]2[epsis]4 [epsis]3[epsis]3 [epsis]3[epsis]4 [epsis]4[epsis]4 Controls 75 (0.07) 832 (0.82) 111 (0.11) 4 (0.01) 57 (0.11) 10 (0.02) 344 (0.68) 88 (0.17) 6 (0.01) AD 40 (0.03) 699 (0.61) 407 (0.36) - 16 (0.03) 24 (0.04) 223 (0.39) 237 (0.41) 73 (0.13) Th1/[Egr]47cs G T GGa GT TT  Controls 562 (0.55) 456 (0.45) 162 (0.32) 238 (0.47) 109 (0.21) AD 515 (0.45) 631 (0.55) 103 (0.18) 308 (0.54) 162 (0.28) -427 TCb T C TT TC CC Controls 874 (0.91) 88 (0.09) 396 (0.82) 82 (0.17) 3 (0.01) AD 1000 (0.92) 86 (0.08) 458 (0.84) 84 (0.16) 1 (0.00) -491 AT A T AAc AT TT Controls 833 (0.82) 185 (0.18) 343 (0.67) 147 (0.29) 19 (0.04) AD 993 (0.87) 153 (0.13) 432 (0.75) 129 (0.23) 12 (0.02) Allele and genotype numbers (frequencies) are presented.

Phrase: "APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "Th1/E47cs"

Phrase: "and -"

Phrase: "491 AT allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "genotype distributions  Allele Genotype APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0523511:APOE [Laboratory Procedure]
   804   C1412481:APOE [Gene or Genome]

Phrase: "[epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]2a"

Phrase: "[epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]4 Controls 75"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "(0.07"

Phrase: ")"

Phrase: "832"

Phrase: "(0.82"

Phrase: ")"

Phrase: "111"

Phrase: "(0.11"

Phrase: ")"

Phrase: "4"

Phrase: "(0.01"

Phrase: ")"

Phrase: "57"

Phrase: "(0.11"

Phrase: ")"

Phrase: "10"

Phrase: "(0.02"

Phrase: ")"

Phrase: "344"

Phrase: "(0.68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: "88"

Phrase: "(0.17"

Phrase: ")"

Phrase: "6"

Phrase: "(0.01"

Phrase: ")"

Phrase: "AD 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "(0.03"

Phrase: ")"

Phrase: "699"

Phrase: "(0.61"

Phrase: ")"

Phrase: "407"

Phrase: "(0.36"

Phrase: ") -"

Phrase: "16"

Phrase: "(0.03"

Phrase: ")"

Phrase: "24"

Phrase: "(0.04"

Phrase: ")"

Phrase: "223"

Phrase: "(0.39"

Phrase: ")"

Phrase: "237"

Phrase: "(0.41"

Phrase: ")"

Phrase: "73"

Phrase: "(0.13"

Phrase: ")"

Phrase: "Th1/[Egr"

Phrase: "]47cs G T GGa GT TT"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "562"

Phrase: "(0.55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: "456"

Phrase: "(0.45"

Phrase: ")"

Phrase: "162"

Phrase: "(0.32"

Phrase: ")"

Phrase: "238"

Phrase: "(0.47"

Phrase: ")"

Phrase: "109"

Phrase: "(0.21"

Phrase: ")"

Phrase: "AD 515"

Phrase: "(0.45"

Phrase: ")"

Phrase: "631"

Phrase: "(0.55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: "103"

Phrase: "(0.18"

Phrase: ")"

Phrase: "308"

Phrase: "(0.54"

Phrase: ")"

Phrase: "162"

Phrase: "(0.28"

Phrase: ") -"

Phrase: "427 TCb T C TT TC CC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C3538933:CC [Cell Component]

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "874"

Phrase: "(0.91"

Phrase: ")"

Phrase: "88"

Phrase: "(0.09"

Phrase: ")"

Phrase: "396"

Phrase: "(0.82"

Phrase: ")"

Phrase: "82"

Phrase: "(0.17"

Phrase: ")"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(0.01"

Phrase: ")"

Phrase: "AD 1000"

Phrase: "(0.92"

Phrase: ")"

Phrase: "86"

Phrase: "(0.08"

Phrase: ")"

Phrase: "458"

Phrase: "(0.84"

Phrase: ")"

Phrase: "84"

Phrase: "(0.16"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(0.00"

Phrase: ") -"

Phrase: "491 AT A T AAc"

Phrase: "AT TT"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "833"

Phrase: "(0.82"

Phrase: ")"

Phrase: "185"

Phrase: "(0.18"

Phrase: ")"

Phrase: "343"

Phrase: "(0.67"

Phrase: ")"

Phrase: "147"

Phrase: "(0.29"

Phrase: ")"

Phrase: "19"

Phrase: "(0.04"

Phrase: ")"

Phrase: "AD 993"

Phrase: "(0.87"

Phrase: ")"

Phrase: "153"

Phrase: "(0.13"

Phrase: ")"

Phrase: "432"

Phrase: "(0.75"

Phrase: ")"

Phrase: "129"

Phrase: "(0.23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "12"

Phrase: "(0.02"

Phrase: ")"

Phrase: "Allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "genotype numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "(frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0439603:Frequencies [Temporal Concept]
   966 E C0376249:frequency [Quantitative Concept]
   966 E C0871396:Frequency [Quantitative Concept]
   966 E C1561548:Frequency [Qualitative Concept]
   966 E C1705502:Frequency [Quantitative Concept]
   916 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: "are"

Phrase: "presented."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.50: The genotypic distributions in control population were in Hardy-Weinberg equilibrium. 

Phrase: "The genotypic distributions in control population"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0032666:Population Distributions [Quantitative Concept]
   753   C0037775:Distributions [Spatial Concept]
   719 E C0520511:distribution [Idea or Concept]
   719 E C1704711:Distribution [Functional Concept]

Phrase: "were in Hardy-Weinberg equilibrium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014653:Equilibrium [Organism Function]
   760   C1547026:Equilibrium [Quantitative Concept]
Processing 00000000.tx.51: aP < 10-4. 

Phrase: "aP < 10-4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1420697:AP-4 [Gene or Genome]
   913   C2984563:AP-4 [Gene or Genome]
   901   C0052141:AP 10 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.52: bNot significant. 

Phrase: "bNot"

Phrase: "significant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.53: cP = 0.005. 

Phrase: "cP = 0.005."
Processing 00000000.tx.54: Table 2. 

Phrase: "Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.55: Combination of the -491 AT, Th1/E47cs and APOE polymorphism alleles in the controls and AD cases APOE and Th1/E47cs polymorphism combination  n [epsis]2/[epsis]3a [epsis]3/[epsis]3 [epsis]3/[epsis]4 [epsis]4/[epsis]4 [epsis]2/[epsis]4 AD cases GG 103 5 60 30 3 5 GT 306 11 113 136 27 19 TT 139 - 49 70 43 - n 571 16 222 236 73 24 Control cases GG 162 41 100 16 - 5 GT 238 20 170 40 2 5 TT 109 - 73 32 4 - n 509 61 343 88 6 10 APOE and -491 AT polymorphism combination  n [epsis]2/[epsis]3a [epsis]3/[epsis]3 [epsis]3/[epsis]4 [epsis]4/[epsis]4 [epsis]2/[epsis]4 AD cases AA 431 6 157 190 67 11 AT 128 8 58 44 6 12 TT 12 2 7 2 - 1 n 261 16 222 102 28 24 Control cases AA 342 24 242 65 5 6 AT 147 34 89 19 1 4 TT 20 3 12 4 - - n 509 61 343 88 6 10 Th1/E47cs and -491 AT polymorphism combination  n [Agr][Agr] [Agr][Sigma] [Sigma][Sigma]  AD cases GG 103 79 22 2 GT 307 226 75 6 TT 162 127 31 4 n 572 432 128 12 Control cases GG 162 111 48 3 GT 238 162 67 9 TT 109 69 32 8 n 509 342 147 20 aThree individuals were [epsis]2/[epsis]2 in control. 

Phrase: "Combination of the -491"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "AT,"

Phrase: "Th1/E47cs"

Phrase: "and"

Phrase: "APOE polymorphism alleles in the controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Alleles [Gene or Genome]

Phrase: "and"

Phrase: "AD cases APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "Th1/E47cs polymorphism combination  n [epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3a"

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]4/"

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]4 AD cases GG 103 5 60 30 3 5 GT 306 11 113 136 27 19 TT 139 - 49 70 43 - n 571 16 222 236 73 24 Control cases GG 162 41 100 16 - 5 GT 238 20 170 40 2 5 TT 109 - 73 32 4 - n 509 61 343 88 6 10 APOE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   779   C0523511:APOE [Laboratory Procedure]
   779   C1412481:APOE [Gene or Genome]
   716   C0283766:AD 6 [Organic Chemical,Pharmacologic Substance]
   702   C0101466:AD 32 [Antibiotic,Organic Chemical]

Phrase: "and -"

Phrase: "491 AT polymorphism combination  n [epsis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0032529:Polymorphism [Genetic Function]
   753   C0205195:Combination [Qualitative Concept]
   753   C1882417:Polymorphism [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3a"

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]4/"

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]4 AD cases AA 431 6 157 190 67 11"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   880   C0617965:AD 11 [Organic Chemical,Pharmacologic Substance]
   835   C0283766:AD 6 [Organic Chemical,Pharmacologic Substance]
   790   C0868928:Cases [Functional Concept]
   790   C1235746:Aa [Plant]
   790   C1533148:Cases [Quantitative Concept]
   790   C1882141:aa [Qualitative Concept]
   756 E C1706255:CASE [Medical Device]
   756 E C1706256:Case [Conceptual Entity]

Phrase: "AT 128 8 58 44 6 12 TT 12 2 7 2 - 1 n 261 16 222 102 28 24 Control cases AA 342 24 242 65 5 6"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   781   C0243148:control [Qualitative Concept]
   781   C0450385:65 [Intellectual Product]
   781   C0868928:Cases [Functional Concept]
   781   C1235746:Aa [Plant]
   781   C1533148:Cases [Quantitative Concept]
   781   C1550141:Control [Substance]
   781   C1882141:aa [Qualitative Concept]
   781   C1882979:Control [Conceptual Entity]
   781   C2587213:Control [Functional Concept]
   781   C3274648:Control [Qualitative Concept]
   748 E C1706255:CASE [Medical Device]
   748 E C1706256:Case [Conceptual Entity]

Phrase: "AT 147 34 89 19 1 4 TT 20 3 12 4"

Phrase: "- -"

Phrase: "n 509 61 343 88 6 10 Th1/E47cs"

Phrase: "and -"

Phrase: "491 AT polymorphism combination  n [Agr"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0032529:Polymorphism [Genetic Function]
   753   C0205195:Combination [Qualitative Concept]
   753   C1882417:Polymorphism [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "]"

Phrase: "[Agr"

Phrase: "]"

Phrase: "[Agr"

Phrase: "]"

Phrase: "[Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "]"

Phrase: "[Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "]"

Phrase: "[Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "]  AD cases GG 103 79 22 2 GT 307 226 75 6 TT 162 127 31 4 n 572 432 128 12 Control cases GG 162 111 48 3 GT 238 162 67 9 TT 109 69 32 8 n 509 342 147 20 aThree individuals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   746   C0027361:Individual [Population Group]
   746   C0237401:Individual [Human]
   717   C0050714:AD 20 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   703   C0101466:AD 32 [Antibiotic,Organic Chemical]

Phrase: "were"

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]2 in control."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0243148:control [Qualitative Concept]
   790   C0740116:+2 [Quantitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C2827735:2+ [Quantitative Concept]
   790   C2981700:2+ [Classification]
   790   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.56: The -491 A and [epsis]4 alleles present a degree of linkage disequilibrium of 26 and 75% in control and AD populations, respectively. 

Phrase: "The -491 A"

Phrase: "and ["

Phrase: "epsis"

Phrase: "]4 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "a degree of linkage disequilibrium of 26"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0441889:Degree [Qualitative Concept]
   748   C0449286:Degree [Quantitative Concept]
   748   C0542560:Degree [Intellectual Product]
   748   C1561545:degree [Quantitative Concept]
   748   C2348088:Degree [Quantitative Concept]

Phrase: "and"

Phrase: "75% in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "AD populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "respectively."
Processing 00000000.tx.57: The Th1/E47cs G and [epsis]2 alleles are in complete linkage disequilibrium in both populations, while the Th1/E47cs T and [epsis]4 alleles show a linkage disequilibrium of 44% in both populations. 

Phrase: "The Th1/E47cs G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "and ["

Phrase: "epsis"

Phrase: "]2 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "are in complete linkage disequilibrium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   806   C1880153:Complete Linkage [Research Activity]
   760   C0023745:linkage [Molecular Function]
   760   C0205197:Complete [Qualitative Concept]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C0725685:COMPLEAT [Food]
   760   C1551058:Are [Quantitative Concept]

Phrase: "in both populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "while"

Phrase: "the Th1/E47cs T"

Phrase: "and ["

Phrase: "epsis"

Phrase: "]4 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a linkage disequilibrium of 44%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "in both populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.58: No linkage disequilibrium was found between -491 AT and Th1/E47cs polymorphisms. 

Phrase: "No linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "found between -491"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "AT"

Phrase: "and"

Phrase: "Th1/E47cs polymorphisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.59: The location of both polymorphisms within the regulatory region of the APOE gene, and their potential effect in vitro reported in hepatoma cells, suggested that these polymorphisms may play a role in the control of APOE expression levels in brain. 

Phrase: "The location of both polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0450429:Location [Spatial Concept]
   760   C1515974:Location [Body Location or Region]

Phrase: "within the regulatory region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the APOE gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412481:APOE gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "their potential effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "reported in hepatoma cells,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   799   C0677626:hepatoma cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0023903:Hepatoma [Neoplastic Process]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C2239176:Hepatoma [Neoplastic Process]
   770   C3282337:Cells [Cell]
   770   C3496591:Reported [Clinical Attribute]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C3273238:Report [Intellectual Product]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the control of APOE expression levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.60: In order to test this hypothesis, we obtained 94 AD or control brain tissues heterozygous for the APOE and measured the percentage of the expression level of the three APOE alleles. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "94 AD"

Phrase: "or"

Phrase: "control brain tissues"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   901   C0440746:brain tissues [Tissue]
   867 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0040300:Tissues [Tissue]
   827   C0243148:control [Qualitative Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "heterozygous for the APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygous [Organism Attribute]

Phrase: "and"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the percentage of the expression level of the three APOE alleles."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0439165:Percentage [Quantitative Concept]
   738   C1549488:Percentage [Idea or Concept]
   738   C1561533:Percentage [Idea or Concept]
Processing 00000000.tx.61: In controls, the [epsis]4 allele was strongly underexpressed compared with the [epsis]3 or the [epsis]2 allele in the [epsis]3[epsis]4 and [epsis]2[epsis]4 brain samples, respectively, while the [epsis]2 and [epsis]3 expressions were almost similar in the [epsis]2[epsis]3 samples (Fig. 1). 

Phrase: "In controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "the [epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "strongly"

Phrase: "underexpressed"

Phrase: "compared with the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "or"

Phrase: "the [epsis"

Phrase: "]2 allele in the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "and ["

Phrase: "epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]4 brain samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "respectively,"

Phrase: "while"

Phrase: "the [epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and ["

Phrase: "epsis"

Phrase: "]3 expressions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:expressions [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "almost similar in the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.62: As suggested by preliminary data (9), there was a clear and consistent increase in the relative [epsis]4 allelic expression between [epsis]3[epsis]4 patients and [epsis]3[epsis]4 controls (34.9  2.7 versus 22.9  2.4%, respectively, P < 10-4). 

Phrase: "As"

Phrase: "suggested by preliminary data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439611:Preliminary [Temporal Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   737   C1705535:Suggest [Idea or Concept]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "was"

Phrase: "a clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "and"

Phrase: "consistent increase in the relative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "[epsis"

Phrase: "]4 allelic expression between"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and ["

Phrase: "epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(34.9  2.7"

Phrase: "versus"

Phrase: "22.9  2.4%,"

Phrase: "respectively,"

Phrase: "P < 10-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.63: A significant decrease in the relative [epsis]2 expression was demonstrated in [epsis]2[epsis]3 AD brains compared with [epsis]2[epsis]3 controls (32.8  4.5 versus 47.8  3.9%, respectively, P = 0.002). 

Phrase: "A significant decrease in the relative"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "[epsis"

Phrase: "]2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "demonstrated"

Phrase: "in [epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3 AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "compared with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1707455:Compared [Activity]

Phrase: "[epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(32.8  4.5"

Phrase: "versus"

Phrase: "47.8  3.9%,"

Phrase: "respectively,"

Phrase: "P = 0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.64: An increased expression of the [epsis]4 allele was also detected between the [epsis]2[epsis]4 AD and controls (46.0  5.4 versus 28.0  2.8%, respectively, P = 0.01). 

Phrase: "An increased expression of the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "detected between the [epsis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]4 AD"

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(46.0  5.4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444499:0/5 [Quantitative Concept]

Phrase: "versus"

Phrase: "28.0  2.8%,"

Phrase: "respectively,"

Phrase: "P = 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.65: Measured values in [epsis]2[epsis]4 AD cases and controls corresponded to the expected values estimated from the other genotypes reinforcing our observations (see Materials and Methods; arrows in Fig. 1). 

Phrase: "Measured values in [epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]4 AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "corresponded to the expected values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0042295:Values [Qualitative Concept]
   760   C1517001:Expected [Idea or Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "estimated from the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750572:Estimated [Quantitative Concept]

Phrase: "other genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "reinforcing"

Phrase: "our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "; arrows in Fig. 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.66: Figure 1. 

Phrase: "Figure 1."
Processing 00000000.tx.67: Differential expression of the APOE mRNA for the three heterozygous genotypes in AD and control cases. 

Phrase: "Differential expression of the APOE mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1515670:mRNA Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "for the three heterozygous genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0019425:heterozygous genotype [Organism Attribute]
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "in AD"

Phrase: "and"

Phrase: "control cases."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0243148:control [Qualitative Concept]
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.68: The average level of expression is indicated by a bold line in each category. 

Phrase: "The average level of expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C3244092:expression level [Idea or Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "indicated by a bold line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205132:Line [Spatial Concept]
   760   C1444656:Indicated [Finding]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]

Phrase: "in each category."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683312:Category [Intellectual Product]
  1000   C1555713:category [Idea or Concept]
Processing 00000000.tx.69: For each brain sample, RT-PCR and semi-quantitation was repeated at least twice. 

Phrase: "For each brain sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "semi-quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "repeated at least twice."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205341:Repeated [Functional Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]
   737 E C1547730:Repeat [Temporal Concept]
   737 E C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.70: Bold arrows indicate the expected values of the [epsis]4 allele percentage in the [epsis]2[epsis]4 samples, calculated from the [epsis]2 and [epsis]4 percentage in the [epsis]2[epsis]3 and [epsis]3[epsis]4 AD and control cases, respectively. 

Phrase: "Bold arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the expected values of the [epsis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0042295:Values [Qualitative Concept]
   753   C1517001:Expected [Idea or Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "]4 allele percentage in the [epsis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]4 samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "calculated from the [epsis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and ["

Phrase: "epsis"

Phrase: "]4 percentage in the [epsis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and ["

Phrase: "epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 AD"

Phrase: "and"

Phrase: "control cases,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0243148:control [Qualitative Concept]
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "respectively."
Processing 00000000.tx.71: The previous epidemiological data suggest that the -491 AT polymorphism and the Th1/E47cs polymorphism may be good candidates to mediate these allelic distortions. 

Phrase: "The previous epidemiological data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the -491 AT polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032529:Polymorphism [Genetic Function]
   770   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "the Th1/E47cs polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "good candidates to"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "these allelic distortions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332482:distortions [Anatomical Abnormality]
   827 E C2919017:Distortion [Qualitative Concept]
Processing 00000000.tx.72: In particular, estimation of the OR associated with the combination of the [epsis]4 and the Th1/E47cs T allele on the same chromosome indicate an estimated increased risk of 1.7 for the heterozygous [epsis]3/[epsis]4 individuals presenting this haplotype, as described previously (10). 

Phrase: "In particular, estimation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0680844:estimation [Mental Process]
   861   C0681916:Estimation [Quantitative Concept]
   861   C0750572:Estimation [Quantitative Concept]

Phrase: "of the OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "associated with the combination of the [epsis"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0205195:Combination [Qualitative Concept]
   748   C1947911:Combination [Physical Object]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "]4"

Phrase: "and"

Phrase: "the Th1/E47cs T allele on the same chromosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Allele [Gene or Genome]

Phrase: "indicate"

Phrase: "an estimated increased risk of 1.7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0966318:RISK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1519101:Risk Estimate [Quantitative Concept]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]

Phrase: "for the heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "presenting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presenting [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "this haplotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.73: Thus, if the [epsis]4 allele is associated with the Th1/E47cs T allele on the same chromosome, while the [epsis]3 allele is associated with the Th1/E47cs G allele on the other, the relative [epsis]4/[epsis]3 mRNA ratio should be significantly increased and associated with AD. 

Phrase: "Thus,"

Phrase: "if"

Phrase: "the [epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "associated with the Th1/E47cs T allele"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0002085:Allele [Gene or Genome]
   748   C1423842:TH1 [Gene or Genome]
   748   C3540579:TH1 [Gene or Genome]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "on the same chromosome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosome [Cell Component]

Phrase: "while"

Phrase: "the [epsis"

Phrase: "]3 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "associated with the Th1/E47cs G allele"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0002085:Allele [Gene or Genome]
   748   C0439267:g% [Quantitative Concept]
   748   C1423842:TH1 [Gene or Genome]
   748   C3540579:TH1 [Gene or Genome]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "on the"

Phrase: "other,"

Phrase: "the relative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0080103:Relative [Family Group]
  1000   C0205345:Relative [Qualitative Concept]
  1000   C1547039:*Relative [Quantitative Concept]

Phrase: "[epsis"

Phrase: "]4/"

Phrase: "[epsis"

Phrase: "]3 mRNA ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "associated with AD."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.74: Conversely, if both [epsis]4 and [epsis]3 alleles are under the control of the same Th1/E47cs allele, either G or T, the level of expression should be similar. 

Phrase: "Conversely,"

Phrase: "if"

Phrase: "both"

Phrase: "[epsis"

Phrase: "]4"

Phrase: "and ["

Phrase: "epsis"

Phrase: "]3 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "are under the control of the same Th1/E47cs allele,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0002085:Allele [Gene or Genome]
   739   C0243148:control [Qualitative Concept]
   739   C0445247:Same [Qualitative Concept]
   739   C1423842:TH1 [Gene or Genome]
   739   C1550141:Control [Substance]
   739   C1551058:Are [Quantitative Concept]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C3274648:Control [Qualitative Concept]
   739   C3540579:TH1 [Gene or Genome]

Phrase: "either G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "or"

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "the level of expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C3244092:expression level [Idea or Concept]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "should"

Phrase: "be"

Phrase: "similar."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.75: Thus, we expected a stronger distortion in Th1/E47cs heterozygotes than in homozygotes. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "a stronger distortion in Th1/E47cs heterozygotes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332482:Distortion [Anatomical Abnormality]
   748   C2919017:Distortion [Qualitative Concept]

Phrase: "than"

Phrase: "in homozygotes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygotes [Organism Attribute]
Processing 00000000.tx.76: This argument is clearly illustrated by our experimental data (Table 3). 

Phrase: "This argument"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680226:argument [Social Behavior]
  1000   C1704769:Argument [Conceptual Entity]

Phrase: "is"

Phrase: "clearly"

Phrase: "illustrated by our experimental data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1511726:Data [Idea or Concept]
   760   C1517586:Experimental [Qualitative Concept]
   760   C3245479:data [Medical Device]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.77: The same approach is valid for the -491 AT mutation. 

Phrase: "The same approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "is"

Phrase: "valid for the -491"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2349099:Valid [Qualitative Concept]

Phrase: "AT mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.78: The influence of both polymorphisms on relative mRNA expression level could be observed only in cases (Fig. 2 and Table 3). 

Phrase: "The influence of both polymorphisms"

Phrase: "on relative mRNA expression level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C1515670:mRNA Expression [Genetic Function]
   861   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only in cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0205171:Only [Quantitative Concept]
   790   C0868928:Cases [Functional Concept]
   790   C1533148:Cases [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]
   756 E C1706255:CASE [Medical Device]
   756 E C1706256:Case [Conceptual Entity]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.79: Affected patients carrying the Th1/E47cs GT or the -491 AT genotypes had the highest and lowest relative levels of expression of [epsis]4 expression, respectively (Fig. 1 and Table 3). 

Phrase: "Affected patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522476:affected patients [Qualitative Concept]
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Th1/E47cs GT"

Phrase: "or"

Phrase: "the -491 AT genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotypes [Organism Attribute]

Phrase: "had"

Phrase: "the highest"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C1522410:Highest [Qualitative Concept]
   966 E C0205250:High [Qualitative Concept]
   966 E C1299351:High [Qualitative Concept]
   966 E C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "and"

Phrase: "lowest relative levels of expression of [epsis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C3244092:expression level [Idea or Concept]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "]4 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "respectively"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.80: The difference in the levels of expression in cases was more pronounced for the Th1/E47cs GT bearers than for the -491 AT bearers (36.6  2.2 versus 33.5  1.3%, respectively, P = 0.004; Fig. 2). 

Phrase: "The difference in the levels of expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "was"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced for the Th1/E47cs GT bearers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1423842:TH1 [Gene or Genome]
   748   C3540579:TH1 [Gene or Genome]

Phrase: "than"

Phrase: "for the -491"

Phrase: "AT bearers"

Phrase: "(36.6  2.2"

Phrase: "versus"

Phrase: "33.5  1.3%,"

Phrase: "respectively,"

Phrase: "P = 0.004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.81: Figure 2. 

Phrase: "Figure 2."
Processing 00000000.tx.82: Differential expression of the [epsis]4 allele in the [epsis]3[epsis]4 AD and control cases, according to the Th1/E47cs genotype. 

Phrase: "Differential expression of the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "]4 allele in the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 AD"

Phrase: "and"

Phrase: "control cases,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0243148:control [Qualitative Concept]
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "according to the Th1/E47cs genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.83: AD cases are denoted by triangles and controls by circles. 

Phrase: "AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "denoted by triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205119:triangles [Conceptual Entity]

Phrase: "and"

Phrase: "controls by circles."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756   C1282913:Circle [Spatial Concept]
   756   C1551714:Circle [Population Group]
Processing 00000000.tx.84: Closed symbols and open symbols correspond to the -491 AT and AA genotypes, respectively. 

Phrase: "Closed symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "and"

Phrase: "open symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "correspond to the -491"

Phrase: "AT"

Phrase: "and"

Phrase: "AA genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "respectively."
Processing 00000000.tx.85: DISCUSSION The deleterious effect of the Th1/E47cs T allele and the protective effect of the -491 T allele described recently (10,11) were confirmed by this large case-control study. 

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "The deleterious effect of the Th1/E47cs T allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "the protective effect of the -491 T allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "(10,"

Phrase: "11"

Phrase: ")"

Phrase: "were"

Phrase: "confirmed by this large case-control study."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   814   C0007328:Case-Control Study [Research Activity]
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   778   C0872128:case control [Health Care Activity]
   774   C0085973:Case Study [Intellectual Product]
   748   C0243148:control [Qualitative Concept]
   748   C0549177:Large [Quantitative Concept]
   748   C0557651:Study [Manufactured Object]
   748   C0750484:Confirmed [Idea or Concept]
   748   C0868928:Case [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C2603343:Study [Research Activity]
   748   C3274648:Control [Qualitative Concept]
   714 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.86: These effects were obvious in the APOE heterozygous population, but not in the homozygous population. 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "obvious in the APOE heterozygous population,"

Phrase: "but"

Phrase: "not in the homozygous population."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0019904:Homozygous [Organism Attribute]
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]
   760   C1518422:Not [Functional Concept]
Processing 00000000.tx.87: These data are not surprising for two reasons: (i) we would expect that APOE [epsis]4 homozygotes with high expressing promoter alleles on both chromosomes, had a higher risk of developing AD than [epsis]4 homozygotes with low expressing promoter alleles. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "surprising for two reasons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205448:Two [Quantitative Concept]
   770   C0392360:reasons [Idea or Concept]

Phrase: ":"

Phrase: "(i"

Phrase: ")"

Phrase: "we"

Phrase: "would"

Phrase: "expect"

Phrase: "that APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsis"

Phrase: "]4 homozygotes with high expressing promoter alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019904:Homozygotes [Organism Attribute]

Phrase: "on both chromosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosomes [Cell Component]

Phrase: "had"

Phrase: "a higher risk of developing AD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   816   C0332167:High risk of [Qualitative Concept]
           High Risk
   756   C3272283:High Risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "[epsis"

Phrase: "]4 homozygotes with low expressing promoter alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019904:Homozygotes [Organism Attribute]
Processing 00000000.tx.88: However, the small size of the [epsis]4/[epsis]4 control population did not allow such an impact to be brought forward; 

Phrase: "However,"

Phrase: "the small size of the [epsis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0748864:small size [Finding]
   753   C0456389:size [Spatial Concept]
   753   C0700321:Small [Quantitative Concept]

Phrase: "]4/"

Phrase: "[epsis"

Phrase: "]4 control population"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0032662:control population [Occupation or Discipline]
   827   C0032659:Population [Quantitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1257890:Population [Population Group]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "such an impact to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1825598:IMPACT [Gene or Genome]

Phrase: "be"

Phrase: "brought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332302:brought [Functional Concept]

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.89: (ii) as a consequence, the measured OR in [epsis]2/[epsis]3/[epsis]4 homozygous individuals mainly depended on the [epsis]3/[epsis]3 population. 

Phrase: "(ii"

Phrase: ")"

Phrase: "as a consequence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "the measured OR in [epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 homozygous individuals mainly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: "depended on the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0725813:depend [Medical Device]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3 population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.90: No effect was found in the latter population whatever the studied promoter polymorphism. 

Phrase: "No effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "found in the latter population"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0032659:Population [Quantitative Concept]
   760   C0150312:Found [Quantitative Concept]
   760   C1257890:Population [Population Group]
   726 E C0243095:Find [Finding]

Phrase: "whatever the studied promoter polymorphism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.91: Furthermore, the apoE3 isoform is considered as the isoform having the lesser effect on AD pathology. 

Phrase: "Furthermore,"

Phrase: "the apoE3 isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "considered as the isoform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   770   C0750591:considered [Idea or Concept]

Phrase: "having"

Phrase: "the lesser effect on AD pathology."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1883473:Ad Effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.92: Table 3. 

Phrase: "Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.93: Relative [epsis]4 allele expression according to the Th1/E47cs and -491 AT polymorphisms in AD and control brain samples  n AD (%) n Controlsa (%) Th1/E47cs GG 4 33.5  1.7 4 22.5  2.5 GT 19 36.3  2.1b 11 22.6  1.9 TT 10 32.4  1.4 10 22.8  2.7 491 AT AA 26 35.3  2.7 15 22.8  2.2 AT 7 33.5  1.3c 10 22.5  2.3 aNot significant. 

Phrase: "Relative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0080103:Relative [Family Group]
  1000   C0205345:Relative [Qualitative Concept]
  1000   C1547039:*Relative [Quantitative Concept]

Phrase: "[epsis"

Phrase: "]4 allele expression according to the Th1/E47cs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "491 AT polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0032529:polymorphisms [Genetic Function]
   756 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in AD"

Phrase: "and"

Phrase: "control brain samples  n AD (%) n Controlsa"

Phrase: "(%"

Phrase: ")"

Phrase: "Th1/E47cs GG 4 33.5  1.7 4 22.5  2.5 GT 19 36.3  2.1b 11 22.6  1.9 TT 10 32.4  1.4 10 22.8  2.7 491"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   780   C0018370:GG [Geographic Area]
   780   C0450345:1B [Intellectual Product]
   780   C1423842:TH1 [Gene or Genome]
   780   C3540579:TH1 [Gene or Genome]

Phrase: "AT AA 26 35.3  2.7 15 22.8  2.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C0444860:Aa 3 [Intellectual Product]
   788   C1235746:Aa [Plant]
   788   C1882141:aa [Qualitative Concept]

Phrase: "AT 7 33.5  1.3c 10 22.5  2.3 aNot"

Phrase: "significant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.94: bP < 10-4. 

Phrase: "bP < 10-4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C1334095:BP-4 [Gene or Genome]
Processing 00000000.tx.95: cP = 0.11. 

Phrase: "cP = 0.11."
Processing 00000000.tx.96: We did not confirm the deleterious effect of the -491 AA genotype described in the [epsis]3[epsis]3 Spanish population (11). 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the deleterious effect of the -491 AA genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "described in the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3 Spanish population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.97: This discrepancy may be explained by the significant difference in the -491 AT genotype distribution observed between the Spanish and the French or American control populations. 

Phrase: "This discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1290905:Discrepancy [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "explained by the significant difference"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "in the -491"

Phrase: "AT genotype distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "observed between the Spanish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086409:SPANISH [Population Group]
   770   C1441672:Observed [Functional Concept]
   770   C3161473:Spanish [Population Group]

Phrase: "and"

Phrase: "the French"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556084:French [Population Group]

Phrase: "or"

Phrase: "American control populations."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   867   C0032662:control population [Occupation or Discipline]
   827   C0032659:Population [Quantitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1257890:Population [Population Group]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.98: Since the AD genotypic frequency was similar in the three studied populations, the deleterious effect of the AA genotype in the [epsis]3[epsis]3 group may only be due to the distribution in the Spanish control population. 

Phrase: "Since"

Phrase: "the AD genotypic frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "was"

Phrase: "similar in the three studied populations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "the deleterious effect of the AA genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "in the [epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3 group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "may"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "be due to the distribution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "in the Spanish control population."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0032662:control population [Occupation or Discipline]
   827   C0032659:Population [Quantitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1257890:Population [Population Group]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.99: When the impacts of these two promoter polymorphisms and the APOE [epsis]4 allele were studied simultaneously in a multiple logistic regression model, we demonstrated that only the Th1/E47cs T allele modified the risk of developing AD independently of the [epsis]4 allele, suggesting that the -491 polymorphisms may play a weaker role compared with Th1/E47cs in the development of AD. 

Phrase: "When"

Phrase: "the impacts of these two promoter polymorphisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1825598:IMPACT [Gene or Genome]

Phrase: "and"

Phrase: "the APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "simultaneously in a multiple logistic regression model,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0206031:Logistic Regression [Research Activity]
   774   C0023965:Logistic Model [Intellectual Product,Quantitative Concept]
   774   C0681923:multiple regression [Qualitative Concept]
   748   C0242415:logistic [Occupational Activity]
   748   C0439064:Multiple [Quantitative Concept]
   748   C0521115:simultaneously [Temporal Concept]
   748   C0684320:Regression [Pathologic Function]
   748   C0684321:Regression [Mental Process]
   748   C3161035:Model [Intellectual Product]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the Th1/E47cs T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "the risk of developing AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "independently of the [epsis"

Phrase: "]4 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the -491 polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a weaker role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "compared with Th1/E47cs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1423842:TH1 [Gene or Genome]
   770   C1707455:Compared [Activity]
   770   C3540579:TH1 [Gene or Genome]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of AD."
Processing 00000000.tx.100: The location of both polymorphisms in the regulatory region of the APOE gene, their effects on the transcriptional activity in hepatoma cells (12) and their impacts in AD population, prompted us to test the hypothesis that they may modulate the APOE expression levels in brain and, therefore, be partly responsible for the marked allelic distortion of the APOE mRNA we observed in AD brain compared with controls in all the heterozygous genotypes. 

Phrase: "The location of both polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0450429:Location [Spatial Concept]
   760   C1515974:Location [Body Location or Region]

Phrase: "in the regulatory region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the APOE gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412481:APOE gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "their effects on the transcriptional activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0677626:hepatoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0023903:Hepatoma [Neoplastic Process]
   861   C2239176:Hepatoma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(12"

Phrase: ")"

Phrase: "and"

Phrase: "their impacts in AD population,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1825598:IMPACT [Gene or Genome]

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the APOE expression levels in brain"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: ","

Phrase: "therefore,"

Phrase: "be"

Phrase: "partly responsible for the marked allelic distortion of the APOE mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1273518:Responsible [Finding]

Phrase: "we"

Phrase: "observed in AD brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1441672:Observed [Functional Concept]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "in all"

Phrase: "the heterozygous genotypes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0019425:heterozygous genotype [Organism Attribute]
   861   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.101: Indeed, the [epsis]4 allele was overexpressed in [epsis]3[epsis]4 and [epsis]2[epsis]4 AD cases and the [epsis]2 allele underexpressed in [epsis]2[epsis]3 AD cases compared with their respective controls. 

Phrase: "Indeed,"

Phrase: "the [epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "in [epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "and ["

Phrase: "epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]4 AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "the [epsis"

Phrase: "]2 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "underexpressed"

Phrase: "in [epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3 AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "compared with their respective controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.102: Consistent with the effects deduced from the case-control study, the [epsis]4 allele expression in AD brain was also correlated with the polymorphisms of the regulatory region of the APOE (Fig. 2): the Th1/E47cs T allele may increase the relative expression of the [epsis]4 allele in AD, while the -491 T allele may decrease it. 

Phrase: "Consistent with the effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "deduced from the case-control study,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0007328:Case-Control Study [Research Activity]
   790   C0872128:case control [Health Care Activity]
   783   C0085973:Case Study [Intellectual Product]
   753   C0243148:control [Qualitative Concept]
   753   C0557651:Study [Manufactured Object]
   753   C0868928:Case [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C2603343:Study [Research Activity]
   753   C3274648:Control [Qualitative Concept]

Phrase: "the [epsis"

Phrase: "]4 allele expression in AD brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "correlated with the polymorphisms of the regulatory region of the APOE"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   756   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0017446:Region [Geographic Area]
   738   C0032529:polymorphisms [Genetic Function]
   738   C0205147:Region [Spatial Concept]
   738   C0220905:regulatory [Regulation or Law]
   738   C0523511:APOE [Laboratory Procedure]
   738   C1412481:APOE [Gene or Genome]
   738   C1704735:Regulatory [Conceptual Entity]
   738   C1707520:Correlated [Qualitative Concept]
   704 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ":"

Phrase: "the Th1/E47cs T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the relative expression of the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "]4 allele in AD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0002085:Allele [Gene or Genome]

Phrase: "while"

Phrase: "the -491 T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "may"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "it."
Processing 00000000.tx.103: Because numerous studies reported contradictory findings in brain and cerebrospinal fluid (CSF) concerning apoE protein level, it is difficult to speculate on the link between APOE mRNA and apoE protein levels (13-17). 

Phrase: "Because"

Phrase: "numerous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "contradictory findings in brain"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   819   C0576471:brain findings [Finding]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "cerebrospinal fluid (CSF) concerning apoE protein level,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0201943:Cerebrospinal fluid protein [Laboratory Procedure]
   818   C0428479:Protein level [Laboratory or Test Result]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0441889:Level [Qualitative Concept]
   795   C0456079:Level [Classification]
   795   C1547707:Level [Geographic Area]
   795   C2946261:Level [Pharmacologic Substance]

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "speculate on the link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "between APOE mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "apoE protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(13-17"

Phrase: ")."
Processing 00000000.tx.104: However, as suggested by Yamada et al., the APOE expression may be decreased by an [epsis]4 gene dosage in AD: the [epsis]3 homozygous AD cases expressed more APOE mRNA than the [epsis]4[epsis]4 AD cases, the [epsis]3[epsis]4 presenting an intermediate mRNA level (18). 

Phrase: "However,"

Phrase: "as"

Phrase: "suggested by Yamada et al.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1705535:Suggest [Idea or Concept]

Phrase: "the APOE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "decreased by an [epsis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "]4 gene dosage in AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0178655:Gene Dosage [Quantitative Concept]
   760   C0178602:Dosage [Quantitative Concept]

Phrase: ":"

Phrase: "the [epsis"

Phrase: "]3 homozygous AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "expressed"

Phrase: "more APOE mRNA than the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]4 AD cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "the [epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "presenting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presenting [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "an intermediate mRNA level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.105: A similar trend was found for proteins in AD brains (14) or in plasma (J. Poirier, personal communication), indicating that both the protein and mRNA levels may be directly correlated during the disease. 

Phrase: "A similar trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521798:trend [Temporal Concept]

Phrase: "was"

Phrase: "found for proteins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "in AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(14"

Phrase: ")"

Phrase: "or in plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032105:Plasma [Body Substance]
   790   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "(J. Poirier,"

Phrase: "personal communication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "both the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "correlated during the disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0012634:Disease [Disease or Syndrome]
   770   C1707520:Correlated [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.106: Underlining the importance of apoE level, the APOE expression has been shown to correlate with A[beta] peptide deposition in transgenic mice (19,20). 

Phrase: "Underlining"

Phrase: "the importance of apoE level,"

Phrase: "the APOE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate with A[beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0330390:Beta [Plant]
   770   C0439096:Beta [Intellectual Product]
   770   C2004068:Beta [Qualitative Concept]

Phrase: "] peptide deposition in transgenic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]

Phrase: "(19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.107: This observation may be very important, since previous reports showed that the APOE gene expression was increased between 2- and 3-fold in AD brains compared with controls regardless of the APOE genotype (18,21). 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "may"

Phrase: "be"

Phrase: "very important,"

Phrase: "since"

Phrase: "previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the APOE gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1412481:APOE gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "increased between 2-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "3-fold in AD brains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "regardless of the APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "(18,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.108: In [epsis]3[epsis]4 AD cases, both the [epsis]3 and [epsis]4 alleles would be overexpressed, but the [epsis]4 allele, due to the promoter mutations, being still more overexpressed than the [epsis]3 allele. 

Phrase: "In [epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 AD cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "both"

Phrase: "the [epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and ["

Phrase: "epsis"

Phrase: "]4 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "would"

Phrase: "be"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: ","

Phrase: "but"

Phrase: "the [epsis"

Phrase: "]4 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "due to the promoter mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "being"

Phrase: "still more"

Phrase: "overexpressed than the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1514559:overexpress [Genetic Function]

Phrase: "]3 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.109: Exacerbation of APOE [epsis]4 expression level may foster the intrinsic deleterious effect of the apoE4 isoform in AD for instance in promoting A[beta] aggregation (2,6,22). 

Phrase: "Exacerbation of APOE"

Phrase: "[epsis"

Phrase: "]4 expression level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C3244092:expression level [Idea or Concept]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "foster"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "the intrinsic deleterious effect of the apoE4 isoform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "in AD"

Phrase: "for instance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "in promoting A[beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "] aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.110: This expression level modulation may be intended not only for neurodegenerative disease, but also for neural development. 

Phrase: "This expression level modulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443264:Modulation [Spatial Concept]
   734   C3244092:expression level [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "intended"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1283828:Intended [Qualitative Concept]
  1000   C1551357:intended [Idea or Concept]

Phrase: "not only for neurodegenerative disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205171:Only [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1720467:Only [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "but"

Phrase: "also for neural development."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0814002:Neural Development [Cell Function,Organism Function]
   805 E C1818230:nerve development [Organ or Tissue Function]
   770   C0243107:development [Physiologic Function]
   770   C0599851:Neural [Functional Concept]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   715 E C0027740:Nerve [Tissue]
   715 E C0027757:NERVE [Tissue]
   715 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.111: Indeed, we observed a strong underexpression of the [epsis]4 allele compared with the [epsis]3 allele in controls. 

Phrase: "Indeed,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a strong underexpression of the [epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "compared with the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "]3 allele in controls."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.112: Although the role of apoE during maturation and ageing is not completely understood yet, the fact that apoE deficient homozygous mice exhibit reversible dendritic alterations and significant learning deficits in the Morris water maze, suggests neurotrophic capabilities for apoE (23-25). 

Phrase: "Although"

Phrase: "the role of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "during maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678723:Maturation [Organism Function]
  1000   C0870861:maturation [Phenomenon or Process]
  1000   C1254042:Maturation [Physiologic Function]

Phrase: "and"

Phrase: "ageing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "is"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: "yet,"

Phrase: "the fact"

Phrase: "that apoE deficient homozygous mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "reversible dendritic alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "significant learning deficits in the Morris water maze,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C2987487:deficits [Qualitative Concept]
   711 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "neurotrophic capabilities for apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2698977:Capability [Qualitative Concept]

Phrase: "(23-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.113: However, the abilities of each isoform may be different since the apoE4 isoform does not have the same effects as the apoE3 isoform on neurite outgrowth (26). 

Phrase: "However,"

Phrase: "the abilities of each isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Abilities [Organism Attribute]

Phrase: "may"

Phrase: "be"

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "since"

Phrase: "the apoE4 isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "the same effects as the apoE3 isoform"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.114: For instance, apoE3, but not apoE4, may stabilize the neuronal cytoskeleton (7). 

Phrase: "For instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "but"

Phrase: "not apoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   861   C2984964:APOE4 [Laboratory Procedure]

Phrase: "may"

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "the neuronal cytoskeleton"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010853:Cytoskeleton [Cell Component]
   861   C1748451:Cytoskeleton [Cell Component]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.115: A global assessment of the modulation of APOE expression is difficult. 

Phrase: "A global assessment of the modulation of APOE expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0281858:Global Assessment [Research Activity]
   742   C1261322:Assessment [Health Care Activity]
   742   C1516048:Assessment [Activity]

Phrase: "is"

Phrase: "difficult."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332218:Difficult [Qualitative Concept]
   928 E C1299586:Difficulty [Finding]
Processing 00000000.tx.116: Indeed, to date, five polymorphisms have been described in the APOE promoter region (10,12). 

Phrase: "Indeed,"

Phrase: "to date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "five polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "described in the APOE promoter region"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017446:Region [Geographic Area]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205147:Region [Spatial Concept]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C1552738:described [Idea or Concept]

Phrase: "(10,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.117: Two of the three polymorphisms studied, seem to play a role in AD. 

Phrase: "Two of the three polymorphisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: ","

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.118: The two remaining have allelic frequencies <1% (12), and therefore cannot explain the effects observed in the case-control and mRNA studies. 

Phrase: "The two remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "have"

Phrase: "allelic frequencies"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   983   C0017270:allelic frequency [Quantitative Concept]
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "<1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "therefore"

Phrase: "cannot"

Phrase: "explain"

Phrase: "the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "observed in the case-control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0872128:case control [Health Care Activity]
   760   C0243148:control [Qualitative Concept]
   760   C0868928:Case [Functional Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "mRNA studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.119: However, it remains possible that other unknown polymorphisms modulate the APOE mRNA level. 

Phrase: "However,"

Phrase: "it"

Phrase: "remains"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "other unknown polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the APOE mRNA level."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.120: These new mutations may be far away from the promoter polymorphisms, for instance in the brain tissue specific element (27,28). 

Phrase: "These new mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C2985439:new mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "be"

Phrase: "far away from the promoter polymorphisms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205108:far [Spatial Concept]

Phrase: "for instance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "in the brain tissue specific element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C1705248:Element [Conceptual Entity]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.121: The interaction between all the putative polymorphisms modifying APOE expression will be very difficult to model. 

Phrase: "The interaction between all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "the putative polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "modifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392747:MODIFY [Functional Concept]

Phrase: "APOE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "will"

Phrase: "be"

Phrase: "very difficult to model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332218:Difficult [Qualitative Concept]
Processing 00000000.tx.122: Various combinations of different mutations may confer a large APOE expression heterogeneity at two levels: (i) the absolute level of APOE expression and (ii) the percentage of expression of one allele compared with the other in heterozygous individuals, adding to the complexity of the association between APOE and AD. 

Phrase: "Various combinations of different mutations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0453882:Combinations [Manufactured Object]
   726 E C0205195:Combination [Qualitative Concept]
   726 E C1947911:Combination [Physical Object]

Phrase: "may"

Phrase: "confer"

Phrase: "a large APOE expression heterogeneity at two levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0019409:Heterogeneity [Qualitative Concept]

Phrase: ":"

Phrase: "(i"

Phrase: ")"

Phrase: "the absolute level of APOE expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C3244092:expression level [Idea or Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "the percentage of expression of one allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "compared with the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "other in heterozygous individuals,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019425:Heterozygous [Organism Attribute]
   770   C0205394:Other [Qualitative Concept]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "adding to the complexity of the association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   714   C1883712:Add [Functional Concept]

Phrase: "between APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "AD."
Processing 00000000.tx.123: Therefore, the variation of the APOE expression induced by the APOE promoter polymorphisms may partly explain the heterogeneity of the impact of the [epsis]4 allele in different ethnic groups (1,29). 

Phrase: "Therefore,"

Phrase: "the variation of the APOE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "induced by the APOE promoter polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205263:Induced [Functional Concept]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "partly"

Phrase: "explain"

Phrase: "the heterogeneity of the impact of the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "]4 allele in different ethnic groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.124: MATERIALS AND METHODS Populations The AD and control samples were Caucasians originating from France. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS Populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "The AD"

Phrase: "and"

Phrase: "control samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "Caucasians"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007457:Caucasians [Population Group]
  1000   C0043157:Caucasians [Population Group]

Phrase: "originating from France."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0016674:France [Geographic Area]
Processing 00000000.tx.125: Diagnoses of probable AD were established according to the DSM-III-R and NINDCS-ADRDA criteria (n = 573; age = 73.8  8.1 years; age of onset = 70.4  7.9 years; 35.9% of men) (30,31). 

Phrase: "Diagnoses of probable AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   802   C0332148:Probable diagnosis [Qualitative Concept]
   770   C0011900:Diagnoses [Finding]
   737 E C1704338:diagnosis [Qualitative Concept]
   737 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "were"

Phrase: "established according to the DSM-III-R"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0220951:DSM III-R [Intellectual Product]
   778   C0444969:III/R [Intellectual Product]
   778   C0679229:DSM-III [Intellectual Product]
   748   C0205090:R- [Spatial Concept]
   748   C0439070:III [Intellectual Product]
   748   C0443211:Established [Qualitative Concept]
   748   C0680240:according [Social Behavior]
   748   C0684010:R. [Professional or Occupational Group]
   748   C1272684:Established [Qualitative Concept]
   748   C1705160:III [Qualitative Concept]
   748   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "NINDCS-ADRDA criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]

Phrase: "(n = 573"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; age = 73.8  8.1 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   895   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: "; age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]

Phrase: "= 70.4  7.9 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "; 35.9% of men) (30,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0025266:Men [Population Group]
   726 E C0024554:MAN [Finding]
   726 E C0086418:Man [Human]

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: The Caucasian controls were defined as subjects without DMS-III-R dementia criteria and with integrity of their cognitive functions (n = 509; age = 74.3  9.9 years; 35.9% of men). 

Phrase: "The Caucasian controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "defined as subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "without DMS-III-R dementia criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0243161:criteria [Intellectual Product]

Phrase: "and with integrity of their cognitive functions"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0392335:Cognitive functions [Mental Process]
   748   C0205266:integrity [Qualitative Concept]
   748   C0542341:Functions [Functional Concept]
   748   C0872403:integrity [Individual Behavior]
   748   C1515981:And [Idea or Concept]
   748   C1516691:Cognitive [Functional Concept]
   748   C1947912:Integrity [Qualitative Concept]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]

Phrase: "(n = 509"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; age = 74.3  9.9 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   895   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: "; 35.9% of men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0025266:Men [Population Group]
   737 E C0024554:MAN [Finding]
   737 E C0086418:Man [Human]

Phrase: ")."
Processing 00000000.tx.127: Each individual or their relatives signed an informed consent. 

Phrase: "Each individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]

Phrase: "or"

Phrase: "their relatives"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0080103:Relatives [Family Group]
   966 E C0205345:Relative [Qualitative Concept]
   966 E C1547039:*Relative [Quantitative Concept]

Phrase: "signed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1519316:Signed [Intellectual Product]
  1000   C1561610:signed [Idea or Concept]
   966 E C0311392:Sign [Finding]
   966 E C1547188:Sign [Idea or Concept]

Phrase: "an informed consent."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0021430:Informed Consent [Regulation or Law]
   861   C1511481:Consent [Functional Concept]
   861   C1522154:Informed [Qualitative Concept]
   861   C1554192:consent [Idea or Concept]
   827 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827 E C0700287:inform [Health Care Activity]
   827 E C1552002:inform [Idea or Concept]
Processing 00000000.tx.128: Brain samples These consisted of 45 controls (age = 80.3  8.6 years; 44.9% of men) and 49 late-onset AD cases (age = 76.5  9.3 years; age of onset = 68.4  10.0 years; 44.4% of men), selected according to their APOE genotype. 

Phrase: "Brain samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "These"

Phrase: "consisted of 45 controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   737   C0243148:control [Qualitative Concept]
   737   C0332529:CONSIST [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "(age = 80.3  8.6 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   895   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: "; 44.9% of men)"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0025266:Men [Population Group]
   737 E C0024554:MAN [Finding]
   737 E C0086418:Man [Human]

Phrase: "and"

Phrase: "49 late-onset AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "(age = 76.5  9.3 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   895   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: "; age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]

Phrase: "= 68.4  10.0 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "; 44.4% of men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0025266:Men [Population Group]
   737 E C0024554:MAN [Finding]
   737 E C0086418:Man [Human]

Phrase: ")"

Phrase: ","

Phrase: "selected according to their APOE genotype."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017431:Genotype [Organism Attribute]
   753   C0523511:APOE [Laboratory Procedure]
   753   C0680240:according [Social Behavior]
   753   C1412481:APOE [Gene or Genome]
   719   C1707391:Select [Activity]
Processing 00000000.tx.129: Eighty-eight samples were extracted from frontal cortex and six from occipital cortex, no difference of relative expressions being observed between those regions. 

Phrase: "Eighty-eight samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "extracted from frontal cortex"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0205123:Frontal [Spatial Concept]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "six from occipital cortex,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0028785:Occipital cortex [Body Part, Organ, or Organ Component]
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C0205452:Six [Quantitative Concept]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C1184145:Occipital [Body Location or Region]
   770   C2700441:Cortex [Plant]

Phrase: "no difference of relative expressions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "being"

Phrase: "observed between those regions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1441672:Observed [Functional Concept]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]
Processing 00000000.tx.130: The mean age was 78.4  8.7 years for the AD cases genotyped [epsis]3[epsis]4 and 75.9  7.5 years for the controls. 

Phrase: "The mean age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "78.4  8.7 years for the AD cases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0439234:years [Temporal Concept]
   708 E C0439508:/year [Temporal Concept]

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "and"

Phrase: "75.9  7.5 years for the controls."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439234:years [Temporal Concept]
   711 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.131: Diagnoses were confirmed by neuropathological examination. 

Phrase: "Diagnoses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0011900:Diagnoses [Finding]
   966 E C1704338:diagnosis [Qualitative Concept]
   966 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "were"

Phrase: "confirmed by neuropathological examination."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0750484:Confirmed [Idea or Concept]
   737 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.132: Genotype The -491 AT, -427 CT, Th1E47cs and APOE genotypes were produced by PCR followed by restriction enzyme digestion of the amplified DNA as described (10-12,32). 

Phrase: "Genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "The -491 AT, -"

Phrase: "427 CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "Th1E47cs"

Phrase: "and"

Phrase: "APOE genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "produced by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "followed by restriction enzyme digestion of the amplified DNA"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   784   C0012906:DNA Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
           Restriction Enzyme
   764   C0332283:Followed by [Temporal Concept]
           followed
   762   C1749889:DNA restriction [Genetic Function]
   742   C0012238:Digestion [Organism Function]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0443288:Restriction [Functional Concept]
   742   C2349986:Digestion [Research Activity]
   708 E C1719822:Follow [Intellectual Product]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(10-12,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.133: APOE allelic quantitation Total RNA extraction from brain tissues, heterozygous for APOE genotype, was performed as described (33) or using RNeasy Mini kit (Qiagen, Germany) and then digested by DNase (Eurogentec, Belgium). 

Phrase: "APOE allelic quantitation Total RNA extraction from brain tissues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0185115:Extraction [Therapeutic or Preventive Procedure]
   742   C0684295:extraction [Laboratory Procedure]

Phrase: "heterozygous for APOE genotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0019425:heterozygous genotype [Organism Attribute]
           Heterozygous

Phrase: "was"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(33"

Phrase: ")"

Phrase: "or"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RNeasy Mini kit (Qiagen,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "digested by DNase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0868946:digested [Physiologic Function]

Phrase: "(Eurogentec,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")."
Processing 00000000.tx.134: No DNA contamination was observed after DNase digestion as detected by PCR of the digested product. 

Phrase: "No DNA contamination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2936628:DNA Contamination [Human-caused Phenomenon or Process]
   861   C0259846:contamination [Human-caused Phenomenon or Process]
   861   C1881659:CONTAMINATION [Event]
   861   C2349974:Contamination [Idea or Concept]

Phrase: "was"

Phrase: "observed after DNase digestion"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0012238:Digestion [Organism Function]
   770   C1441672:Observed [Functional Concept]
   770   C2349986:Digestion [Research Activity]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "as"

Phrase: "detected by PCR of the digested product."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0442726:Detected [Finding]
   748   C0677874:pCR [Finding]
   748   C0868946:digested [Physiologic Function]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.135: APOE mRNAs were amplified by RT-PCR and allele quantitation was performed as described previously (9) by measuring a ratio of expression of two alleles in heterozygotes in order to avoid problems due to post-mortem delay, agonal state and cell population density. 

Phrase: "APOE mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "amplified by RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "allele quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(9"

Phrase: ")"

Phrase: "by measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "a ratio of expression of two alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "in heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "avoid"

Phrase: "problems due to post-mortem delay,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1546466:Problems [Idea or Concept]
   719 E C0033213:Problem [Finding]

Phrase: "agonal state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "cell population density."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0162339:Cell Density [Quantitative Concept]
   901   C0032665:Population Density [Quantitative Concept]
   827   C0178587:density [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.136: Statistical analysis The SAS software release 6.10 was used (SAS Institute, Cary, NC). 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "The SAS software release 6.10"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   875   C1822613:SAS-6 [Gene or Genome]
   804   C0030685:Release [Health Care Activity]
   804   C0037585:Software [Intellectual Product,Manufactured Object]
   804   C0391871:Release [Functional Concept]
   804   C0439180:% release [Quantitative Concept]
   804   C0605290:SAS [Organic Chemical]
   804   C0680255:release [Health Care Activity]
   804   C1283071:Release [Functional Concept]
   804   C1426104:SAS [Gene or Genome]
   804   C1823519:SAS [Gene or Genome]
   804   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(SAS Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Cary,"

Phrase: "NC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.137: Univariate analysis was performed using Pearson's [chi]2 test. 

Phrase: "Univariate analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683962:univariate analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Pearson's"

Phrase: "[chi]2 test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
Processing 00000000.tx.138: In the multivariate analysis, we coded the genotypes of each subject as dummy variables according to the tested hypotheses (at least one Th1/E47cs T allele: TT+TG/GG, at least one -491 T allele: TT+AT/AA and at least one [epsis]4 allele). 

Phrase: "In the multivariate analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026777:Multivariate Analysis [Quantitative Concept]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "coded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0009219:code [Occupational Activity]
   966   C0805701:Code [Intellectual Product]

Phrase: "the genotypes of each subject"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017431:Genotypes [Organism Attribute]

Phrase: "as dummy variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]

Phrase: "according to the tested hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "("

Phrase: "at least one Th1/E47cs T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0002085:Allele [Gene or Genome]

Phrase: ":"

Phrase: "TT+TG/GG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018370:GG [Geographic Area]

Phrase: "at least one -491 T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0002085:Allele [Gene or Genome]

Phrase: ":"

Phrase: "TT+AT/AA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1235746:Aa [Plant]
   827   C1882141:aa [Qualitative Concept]

Phrase: "and at least one [epsis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205447:One [Quantitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.139: The effects of these variables on the disease were assessed with a multiple logistic regression model adjusted for age and gender. 

Phrase: "The effects of these variables"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "were"

Phrase: "assessed with a multiple logistic regression model"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0206031:Logistic Regression [Research Activity]
   774   C0023965:Logistic Model [Intellectual Product,Quantitative Concept]
   774   C0681923:multiple regression [Qualitative Concept]
   748   C0242415:logistic [Occupational Activity]
   748   C0439064:Multiple [Quantitative Concept]
   748   C0684320:Regression [Pathologic Function]
   748   C0684321:Regression [Mental Process]
   748   C1516048:Assessed [Activity]
   748   C3161035:Model [Intellectual Product]

Phrase: "adjusted for age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C0456081:Adjusted [Functional Concept]

Phrase: "and"

Phrase: "gender."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]
Processing 00000000.tx.140: Comparison of the allelic expression was performed using Wilcoxon test. 

Phrase: "Comparison of the allelic expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Wilcoxon test."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871608:Wilcoxon Test [Intellectual Product]
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
Processing 00000000.tx.141: We calculated the expected range of values of [epsis]4 percentage in [epsis]2[epsis]4 AD and control individuals using the extreme values obtained for the [epsis]2 and the [epsis]4 percentages in the [epsis]3[epsis]4 and [epsis]2[epsis]3 AD and control samples, respectively (the [epsis]3 allele being used as reference). 

Phrase: "We"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "the expected range of values of [epsis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1547411:Value range [Idea or Concept]
   748   C1514721:Range [Quantitative Concept]
   748   C2348147:Range [Quantitative Concept]
   748   C3542016:Range [Intellectual Product]

Phrase: "]4 percentage in [epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]4 AD"

Phrase: "and"

Phrase: "control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the extreme values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "obtained for the [epsis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "the [epsis"

Phrase: "]4 percentages in the [epsis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0439165:Percentage [Quantitative Concept]
   726   C1549488:Percentage [Idea or Concept]
   726   C1561533:Percentage [Idea or Concept]

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "and ["

Phrase: "epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3 AD"

Phrase: "and"

Phrase: "control samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "respectively"

Phrase: "("

Phrase: "the [epsis"

Phrase: "]3 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "being"

Phrase: "used as reference"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C1273517:used [Finding]
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.142: ACKNOWLEDGEMENTS J.-C.L. is a recipient of the Ministre de l'Enseignement Suprieur et de la Recherche (MESR). 

Phrase: "ACKNOWLEDGEMENTS J.-C.L."

Phrase: "is"

Phrase: "a recipient of the Ministre de l'Enseignement Suprieur et de la"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1709854:Recipient [Human]

Phrase: "Recherche"

Phrase: "(MESR"

Phrase: ")."
Processing 00000000.tx.143: This work was supported by the Institut National pour la Sant et la Recherche Mdicale (INSERM), the Institut Pasteur de Lille, the Conseil Rgional du Nord-Pas de Calais `axe rgional de recherche sur les maladies neurodgnratives et le vieillissement crbral' (M.-C.C.-H., P.A. and F.P.) and the Fondation pour la Recherche Mdicale. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Institut National pour la Sant et la Recherche Mdicale (INSERM),"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   736   C0023031:La [Element, Ion, or Isotope]
   736   C1521721:Supported [Conceptual Entity]
   736   C3245503:national [Intellectual Product]
   703 E C0183683:Support [Medical Device]

Phrase: "the Institut Pasteur de Lille,"

Phrase: "the Conseil Rgional du Nord-Pas de Calais `axe rgional de recherche sur les maladies neurodgnratives et le vieillissement crbral'"

Phrase: "(M.-C.C.-H.,"

Phrase: "P.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "F.P.)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "the Fondation"

Phrase: "pour"

Phrase: "la Recherche Mdicale."
Processing 00000000.tx.144: REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.145: Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., Myers, R.H., Pericak-Vance, M.A., Risch, N. and van Duijn., C.M. 

Phrase: "Farrer,"

Phrase: "L.A.,"

Phrase: "Cupples,"

Phrase: "L.A.,"

Phrase: "Haines,"

Phrase: "J.L., Hyman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kukull,"

Phrase: "W."

Phrase: "A.,"

Phrase: "Mayeux,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Myers,"

Phrase: "R.H.,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Pericak-Vance,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Risch,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "van Duijn.,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.146: (1997) Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Effects of age,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "sex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "ethnicity on the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015031:Ethnicity [Population Group]
   770   C0243103:ethnicity [Qualitative Concept]

Phrase: "between apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.147: A meta-analysis. 

Phrase: "A meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.148: APOE and Alzheimer Disease Meta Analysis Consortium. 

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer Disease Meta Analysis Consortium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1513822:Consortium [Professional or Occupational Group]
   804   C1880171:Consortium [Professional or Occupational Group]
Processing 00000000.tx.149: J. 

Phrase: "J."
Processing 00000000.tx.150: Am. 

Phrase: "Am."
Processing 00000000.tx.151: Med. 

Phrase: "Med."
Processing 00000000.tx.152: Assoc., 278, 1349-1356. 

Phrase: "Assoc.,"

Phrase: "278,"

Phrase: "1349-1356."
Processing 00000000.tx.153: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.154: Strittmatter, W.J., Weisgraber, K.H., Huang, D.Y., Dong, L.-M., Salvesen, G.S., Pericak-Vance, M., Schmechel, D., Saunders, A.M., Goldgaber, D. and Roses, A.D. 

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Huang,"

Phrase: "D."

Phrase: "Y.,"

Phrase: "Dong,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Salvesen,"

Phrase: "G.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Goldgaber,"

Phrase: "D."

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.155: (1993) Binding of human apolipoprotein E to synthetic amyloid [beta] peptide: isoform-specific effects and implications for late-onset Alzheimer disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Binding of human apolipoprotein E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2247768:apolipoprotein binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to synthetic amyloid [beta] peptide"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   923   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   902   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]

Phrase: ":"

Phrase: "isoform-specific effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "implications for late-onset Alzheimer disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
Processing 00000000.tx.156: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.157: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.158: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.159: USA, 90, 8098-8102. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "8098-8102."
Processing 00000000.tx.160: MEDLINE Abstract 3. 

Phrase: "MEDLINE Abstract 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.161: Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. 

Phrase: "Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035853:Roses [Plant]
   793 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Haines,"

Phrase: "J.L."

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.162: (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Gene dose of apolipoprotein E type 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in late-onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.163: Science, 261, 921-923. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "261,"

Phrase: "921-923."
Processing 00000000.tx.164: MEDLINE Abstract 4. 

Phrase: "MEDLINE Abstract 4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.165: Chartier-Harlin, M.-C., Parfitt, M., Legrain, S., Prez-Tur, J., Brousseau, T., Evans, A., Berr, C., Vidal, O., Roques, P., Gourlet, V., Fruchart, J.C., Delacourte, A., Rossor, M. and Amouyel, P. 

Phrase: "Chartier-Harlin,"

Phrase: "M.-C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Parfitt,"

Phrase: "M."

Phrase: ","

Phrase: "Legrain,"

Phrase: "S."

Phrase: ","

Phrase: "Prez-Tur,"

Phrase: "J.,"

Phrase: "Brousseau,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Evans,"

Phrase: "A.,"

Phrase: "Berr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Vidal,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Roques,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gourlet,"

Phrase: "V.,"

Phrase: "Fruchart,"

Phrase: "J.C., Delacourte,"

Phrase: "A.,"

Phrase: "Rossor,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Amouyel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.166: (1994) Apolipoprotein E [epsis]4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4 allele as a major risk factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Allele [Gene or Genome]

Phrase: "for sporadic early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "forms of Alzheimer's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "analysis of the 19q13.2 chromosomal region."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C0853259:chromosomal analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   738 E C0200867:Chromosome analysis [Laboratory Procedure]
Processing 00000000.tx.167: Hum. 

Phrase: "Hum."
Processing 00000000.tx.168: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.169: Genet., 3, 569-574. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "569-574."
Processing 00000000.tx.170: MEDLINE Abstract 5. 

Phrase: "MEDLINE Abstract 5."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.171: Corder, E.H., Saunders, A.M., Risch, N.J., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Rimmler, J.B., Locke, P.A., Conneally, P.M., Schmader, K.E., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. 

Phrase: "Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Risch,"

Phrase: "N.J.,"

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Rimmler,"

Phrase: "J.B.,"

Phrase: "Locke,"

Phrase: "P.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Conneally,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Schmader,"

Phrase: "K.E.,"

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035853:Roses [Plant]
   793 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Haines,"

Phrase: "J.L."

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.172: (1994) Protective effect of apolipoprotein E type 2 for late-onset Alzheimer's disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Protective effect of apolipoprotein E type 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "for late-onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.173: Nature Genet., 7, 180-184. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "180-184."
Processing 00000000.tx.174: MEDLINE Abstract 6. 

Phrase: "MEDLINE Abstract 6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.175: Evans, K., Berger, E.P., Cho, C.G., Weisgraber, K.H. and Lansburry, P.T. 

Phrase: "Evans,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Berger,"

Phrase: "E.P.,"

Phrase: "Cho,"

Phrase: "C.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Weisgraber,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lansburry,"

Phrase: "P.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.176: (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implication for the pathogenesis and treatment of Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a kinetic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0022702:kinetic [Natural Phenomenon or Process]
   944 E C0026597:Motion [Natural Phenomenon or Process]
   944 E C0687704:Motions [Functional Concept]
   928 E C0022699:Kineses [Individual Behavior]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a thermodynamic inhibitor of amyloid formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: ":"

Phrase: "implication for the pathogenesis"

Phrase: "and"

Phrase: "treatment of Alzheimer's disease."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   881   C1979617:Alzheimer's disease treatment [Therapeutic or Preventive Procedure]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.177: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.178: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.179: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.180: USA, 92, 763-767. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "92,"

Phrase: "763-767."
Processing 00000000.tx.181: MEDLINE Abstract 7. 

Phrase: "MEDLINE Abstract 7."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.182: Miyata, M. and Smith, J.D. 

Phrase: "Miyata,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J.D."
Processing 00000000.tx.183: (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and [beta]-amyloid peptides. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Apolipoprotein E allele-specific antioxidant activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   895   C1325281:apolipoprotein activity [Molecular Function]
   827   C1148564:antioxidant activity [Molecular Function]
   799   C0003402:Antioxidant [Pharmacologic Substance]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "effects on cytotoxicity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "by oxidative insults"

Phrase: "and ["

Phrase: "beta]-amyloid peptides."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C2825879:Amyloid, Beta [Laboratory Procedure]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]
Processing 00000000.tx.184: Nature Genet., 14, 55-60. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "14,"

Phrase: "55-60."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]
Processing 00000000.tx.185: MEDLINE Abstract 8. 

Phrase: "MEDLINE Abstract 8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.186: Strittmatter, W.J., Weisgraber, K.H., Goedert, M., Saunders, A.M., Huang, D., Corder, E.H., Dong, L.-M., Jakes, R., Alberts, M.J., Gilbert, J.R., Han, S.H., Hulette, C., Einstein, G., Schmechel, D.E., Pericak-Vance, M.A. and Roses, A.D. 

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Huang,"

Phrase: "D."

Phrase: ","

Phrase: "Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Dong,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Alberts,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hulette,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Einstein,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Pericak-Vance,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.187: (1994) Hypotesis: microtubule instability and paired helical filament formation in the Alzheimer disease are related to Apolipoprotein E genotype. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Hypotesis"

Phrase: ":"

Phrase: "microtubule instability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1444783:Instability [Finding]

Phrase: "and"

Phrase: "paired helical filament formation in the Alzheimer disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "are"

Phrase: "related to Apolipoprotein E genotype."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017431:Genotype [Organism Attribute]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.188: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.189: Neurol., 125, 163-171. 

Phrase: "Neurol.,"

Phrase: "125,"

Phrase: "163-171."
Processing 00000000.tx.190: MEDLINE Abstract 9. 

Phrase: "MEDLINE Abstract 9."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.191: Lambert, J.-C., Prez-Tur, J., Dupire, M.J., Galasko, D., Mann, D., Amouyel, P., Hardy, J., Delacourte, A. and Chartier-Harlin, M.-C. 

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J.-C., Prez-Tur,"

Phrase: "J.,"

Phrase: "Dupire,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Galasko,"

Phrase: "D."

Phrase: ","

Phrase: "Mann,"

Phrase: "D."

Phrase: ","

Phrase: "Amouyel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Delacourte,"

Phrase: "A."

Phrase: "and"

Phrase: "Chartier-Harlin,"

Phrase: "M.-C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.192: (1997) Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Distortion of allelic expression of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332482:Distortion [Anatomical Abnormality]
   748   C2919017:Distortion [Qualitative Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.193: Hum. 

Phrase: "Hum."
Processing 00000000.tx.194: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.195: Genet., 6, 2151-2154. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "6,"

Phrase: "2151-2154."
Processing 00000000.tx.196: MEDLINE Abstract 10. 

Phrase: "MEDLINE Abstract 10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.197: Lambert, J.-C., Pasquier, F., Cottel, D., Frigard, B., Amouyel, P. and Chartier-Harlin., M.-C. 

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J.-C., Pasquier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cottel,"

Phrase: "D."

Phrase: ","

Phrase: "Frigard,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Amouyel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Chartier-Harlin.,"

Phrase: "M.-C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.198: (1998) A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's Disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A new polymorphism in the APOE promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with risk of developing Alzheimer's Disease."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0243083:associated disease [Pathologic Function]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.199: Hum. 

Phrase: "Hum."
Processing 00000000.tx.200: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.201: Genet, 7, 533-540. 

Phrase: "Genet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "533-540."
Processing 00000000.tx.202: MEDLINE Abstract 11. 

Phrase: "MEDLINE Abstract 11."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.203: Bullido, M.J., Artiga, M.J., Recuero, M., Sastre, I., Garcia, M.A., Aldudo, J., Lendon, C., Han, S.W., Morris, J.C., Frank, A., Vazquez, J., Goate, A. and Valdivieso, F. 

Phrase: "Bullido,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Artiga,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Recuero,"

Phrase: "M."

Phrase: ","

Phrase: "Sastre,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Aldudo,"

Phrase: "J.,"

Phrase: "Lendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "S.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Morris,"

Phrase: "J.C., Frank,"

Phrase: "A.,"

Phrase: "Vazquez,"

Phrase: "J.,"

Phrase: "Goate,"

Phrase: "A."

Phrase: "and"

Phrase: "Valdivieso,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.204: (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A polymorphism in the regulatory region of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035647:Risk [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for Alzheimer's dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.205: Nature Genet., 18, 69-71. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "69-71."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450388:69 [Intellectual Product]
   861   C0450389:71 [Intellectual Product]
Processing 00000000.tx.206: MEDLINE Abstract 12. 

Phrase: "MEDLINE Abstract 12."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.207: Artiga, M.J., Bullido, M.J., Sastre, I., Recuero, M., Garcia, M.A., Aldudo, J., Vazquez, J. and Valdivieso, F. 

Phrase: "Artiga,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Bullido,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Sastre,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Recuero,"

Phrase: "M."

Phrase: ","

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Aldudo,"

Phrase: "J.,"

Phrase: "Vazquez,"

Phrase: "J."

Phrase: "and"

Phrase: "Valdivieso,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.208: (1998) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   754   C0678951:gene polymorphisms [Genetic Function]
   738   C0032529:polymorphisms [Genetic Function]
   704 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.209: FEBS Lett., 421, 105-108. 

Phrase: "FEBS Lett.,"

Phrase: "421,"

Phrase: "105-108."
Processing 00000000.tx.210: MEDLINE Abstract 13. 

Phrase: "MEDLINE Abstract 13."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.211: Lefranc, D., Vermersch, P., Dallongeville, J., Daems-Monpeurt, C., Petit, H. and Delacourte, A. 

Phrase: "Lefranc,"

Phrase: "D."

Phrase: ","

Phrase: "Vermersch,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dallongeville,"

Phrase: "J.,"

Phrase: "Daems-Monpeurt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Petit,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Delacourte,"

Phrase: "A."
Processing 00000000.tx.212: (1996) Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Relevance of the quantification of apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevance [Qualitative Concept]

Phrase: "in the cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.213: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.214: Lett., 212, 91-94. 

Phrase: "Lett.,"

Phrase: "212,"

Phrase: "91-94."
Processing 00000000.tx.215: MEDLINE Abstract 14. 

Phrase: "MEDLINE Abstract 14."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.216: Bertrand, P., Poirier, J., Oda, T., Finch, C.E. and Pasinetti, G.M. 

Phrase: "Bertrand,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Poirier,"

Phrase: "J.,"

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Pasinetti,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.217: (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Association of apolipoprotein E genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with brain levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0441889:Levels [Qualitative Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "apolipoprotein J"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413514:APOLIPOPROTEIN J [Gene or Genome]
  1000   C2609437:Apolipoprotein J [Laboratory Procedure]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(clusterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055966:Clusterin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413514:CLUSTERIN [Gene or Genome]

Phrase: ")"

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.218: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.219: Brain Res., 33, 174-178. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "33,"

Phrase: "174-178."
Processing 00000000.tx.220: 15. 

Phrase: "15."
Processing 00000000.tx.221: Harr, S.D., Vint, L., Hollister, R., Hyman, B.T. and Mendez, A.J. 

Phrase: "Harr,"

Phrase: "S.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Vint,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hollister,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hyman,"

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]

Phrase: "and"

Phrase: "Mendez,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.222: (1996) Brain expression of Apolipoprotein E, J and A-I in Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Brain expression of Apolipoprotein E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "J"

Phrase: "and"

Phrase: "A-I in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.223: J. 

Phrase: "J."
Processing 00000000.tx.224: Neurochem., 66, 2429-2435. 

Phrase: "Neurochem.,"

Phrase: "66,"

Phrase: "2429-2435."
Processing 00000000.tx.225: MEDLINE Abstract 16. 

Phrase: "MEDLINE Abstract 16."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.226: Lehtimki, T., Pirttil, T., Mehta, P.D., Wiesniewski, H.M., Frey, H. and Nikkari, T. 

Phrase: "Lehtimki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pirttil,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mehta,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Wiesniewski,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Frey,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Nikkari,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.227: (1995) Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Apolipoprotein E (apoE) polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "its influence on ApoE concentrations"

Phrase: "in the cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "in Finnish patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.228: Hum. 

Phrase: "Hum."
Processing 00000000.tx.229: Genet., 95, 39-42. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "95,"

Phrase: "39-42."
Processing 00000000.tx.230: MEDLINE Abstract 17. 

Phrase: "MEDLINE Abstract 17."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.231: Merched, A., Blain, H., Visvikis, S., Herbeth, B., Jeandel, C. and Siest, G. 

Phrase: "Merched,"

Phrase: "A.,"

Phrase: "Blain,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Visvikis,"

Phrase: "S."

Phrase: ","

Phrase: "Herbeth,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jeandel,"

Phrase: "C."

Phrase: "and"

Phrase: "Siest,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.232: (1997) Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cerebrospinal fluid apolipoprotein E level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0441889:Level [Qualitative Concept]
   804   C0456079:Level [Classification]
   804   C1547707:Level [Geographic Area]
   804   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "increased in late-onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   814   C0814122:late disease onset [Finding]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205087:Late [Temporal Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0332162:Onset [Qualitative Concept]
   753   C0442805:Increased [Functional Concept]
   737   C0277564:Acquired disease [Disease or Syndrome]
Processing 00000000.tx.233: J. 

Phrase: "J."
Processing 00000000.tx.234: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.235: Sci., 145, 33-39. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "145,"

Phrase: "33-39."
Processing 00000000.tx.236: MEDLINE Abstract 18. 

Phrase: "MEDLINE Abstract 18."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.237: Yamada, T., Kondo, A., Takamatsu, J., Tateishi, J. and Goto, I. 

Phrase: "Yamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kondo,"

Phrase: "A.,"

Phrase: "Takamatsu,"

Phrase: "J.,"

Phrase: "Tateishi,"

Phrase: "J."

Phrase: "and"

Phrase: "Goto,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.238: (1995) Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Apolipoprotein E mRNA in the brains of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.239: J. 

Phrase: "J."
Processing 00000000.tx.240: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.241: Sci., 129, 56-61. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "129,"

Phrase: "56-61."
Processing 00000000.tx.242: MEDLINE Abstract 19. 

Phrase: "MEDLINE Abstract 19."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.243: Bales, K.R., Verina, T., Dodel, R.C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E.M., Little, S.P., Cummins, D.J., Piccardo, P., Ghetti, B. and Paul, S.M. 

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Verina,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dodel,"

Phrase: "R.C., Du,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3540681:DU [Idea or Concept]
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "Y.,"

Phrase: "Altstiel,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bender,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0491941:BENDER [Medical Device]

Phrase: "M."

Phrase: ","

Phrase: "Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Johnstone,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Little,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "S.P.,"

Phrase: "Cummins,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Piccardo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Paul,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.244: (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Lack of apolipoprotein E dramatically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332268:lack [Qualitative Concept]

Phrase: "reduces"

Phrase: "amyloid beta-peptide deposition."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0011560:Amyloid deposition [Pathologic Function]
   902   C1705760:Amyloid Deposition [Finding]
   812   C0333562:Deposition [Functional Concept]
   756   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   756   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.245: Nature Genet., 17, 263-264. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "17,"

Phrase: "263-264."
Processing 00000000.tx.246: MEDLINE Abstract 20. 

Phrase: "MEDLINE Abstract 20."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.247: Igeta, Y., Kawarabayashi, T., Sato, M., Yamada, N., Matsubara, E., Ishiguro, K., Kanai, M., Tomidokoro, Y., Osuga, J., Okamoto, K., Hirai, S. and Shoji, M. 

Phrase: "Igeta,"

Phrase: "Y.,"

Phrase: "Kawarabayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sato,"

Phrase: "M."

Phrase: ","

Phrase: "Yamada,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsubara,"

Phrase: "E.,"

Phrase: "Ishiguro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kanai,"

Phrase: "M."

Phrase: ","

Phrase: "Tomidokoro,"

Phrase: "Y.,"

Phrase: "Osuga,"

Phrase: "J.,"

Phrase: "Okamoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hirai,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Shoji,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.248: (1997) Apolipoprotein E accumulates with the progression of A beta deposition in transgenic mice. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accumulates with the progression of A beta deposition"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0242656:progression [Pathologic Function]
   744   C0330390:Beta [Plant]
   744   C0333562:Deposition [Functional Concept]
   744   C0439096:Beta [Intellectual Product]
   744   C0449258:Progression [Functional Concept]
   744   C2004068:Beta [Qualitative Concept]

Phrase: "in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.249: J. 

Phrase: "J."
Processing 00000000.tx.250: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.251: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.252: Neurol., 56, 1228-1235. 

Phrase: "Neurol.,"

Phrase: "56,"

Phrase: "1228-1235."
Processing 00000000.tx.253: 21. 

Phrase: "21."
Processing 00000000.tx.254: Diedrich, J.F., Minnigan, H., Carp, R.I., Whitaker, J.N., Race, R., Frey, W. 

Phrase: "Diedrich,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Minnigan,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Carp,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007284:carp [Fish]
  1000   C0328038:Carp [Fish]
  1000   C0677526:Carp [Food]

Phrase: "R.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Whitaker,"

Phrase: "J.N., Race,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034510:Race [Population Group]
   827   C1706779:RACE [Gene or Genome]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frey,"

Phrase: "W."
Processing 00000000.tx.255: II and Haase, A.T. 

Phrase: "II"

Phrase: "and"

Phrase: "Haase,"

Phrase: "A.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]
Processing 00000000.tx.256: (1991) Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of Apolipoprotein E and Cathepsin D in astrocytes. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Neuropathological changes in scrapie"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "associated with increased expression of Apolipoprotein E"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "Cathepsin D in astrocytes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332805:CATHEPSIN D [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.257: J. 

Phrase: "J."
Processing 00000000.tx.258: Virol., 65, 4759-4768. 

Phrase: "Virol.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "4759-4768."
Processing 00000000.tx.259: MEDLINE Abstract 22. 

Phrase: "MEDLINE Abstract 22."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.260: Berr, C., Hauw, J.J., Delaere, P., Duyckaerts, C. and Amouyel, P. 

Phrase: "Berr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hauw,"

Phrase: "J.J.,"

Phrase: "Delaere,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Duyckaerts,"

Phrase: "C."

Phrase: "and"

Phrase: "Amouyel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.261: (1994) Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E allele epsilon 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   911   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   840   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002085:Allele [Gene or Genome]
   804   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439098:Epsilon [Intellectual Product]

Phrase: "is"

Phrase: "linked to increased deposition of the amyloid beta-peptide"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   790   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   790   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   764   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   762   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   762   C1705760:Amyloid Deposition [Finding]
   762 E C2825879:Amyloid, Beta [Laboratory Procedure]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0205217:Increased [Quantitative Concept]
   742   C0330390:Beta [Plant]
   742   C0333562:Deposition [Functional Concept]
   742   C0439096:Beta [Intellectual Product]
   742   C0442805:Increased [Functional Concept]
   742   C2004068:Beta [Qualitative Concept]
   708   C1517892:Link [Intellectual Product]
   708   C1704666:Link [Intellectual Product]

Phrase: "(A-beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: ")"

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "with"

Phrase: "or without Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.262: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.263: Lett., 178, 221-224. 

Phrase: "Lett.,"

Phrase: "178,"

Phrase: "221-224."
Processing 00000000.tx.264: MEDLINE Abstract 23. 

Phrase: "MEDLINE Abstract 23."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0450348:23 [Quantitative Concept]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.265: Masliah, E., Mallory, M., Ge, N., Alford, M., Veinbergs, I. and Roses, A.D. 

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Ge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538705:GE [Gene or Genome]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Alford,"

Phrase: "M."

Phrase: ","

Phrase: "Veinbergs,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.266: (1995) Neurodegeneration in the central nervous system of apoE-deficient mice. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neurodegeneration in the central nervous system of apoE-deficient mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.267: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.268: Neurol., 136, 107-122. 

Phrase: "Neurol.,"

Phrase: "136,"

Phrase: "107-122."
Processing 00000000.tx.269: MEDLINE Abstract 24. 

Phrase: "MEDLINE Abstract 24."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.270: Gordon, I., Grauer, E., Genis, I., Sehayek, E. and Michaelson, D.M. 

Phrase: "Gordon,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Grauer,"

Phrase: "E.,"

Phrase: "Genis,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sehayek,"

Phrase: "E."

Phrase: "and"

Phrase: "Michaelson,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.271: (1995) Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Memory deficits"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0233794:Memory Deficits [Mental or Behavioral Dysfunction]
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "and"

Phrase: "cholinergic impairments in apolipoprotein E-deficient mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0684336:Impairments [Pathologic Function]
   748   C2598156:Impairments [Clinical Attribute]
Processing 00000000.tx.272: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.273: Lett., 199, 1-4. 

Phrase: "Lett.,"

Phrase: "199,"

Phrase: "1-4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.274: MEDLINE Abstract 25. 

Phrase: "MEDLINE Abstract 25."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.275: Masliah, E., Samuel, W., Veinbergs, I., Mallory, M., Mante, M. and Saitoh, T. 

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Samuel,"

Phrase: "W.,"

Phrase: "Veinbergs,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Mante,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.276: (1997) Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "cognitive impairment in apoE-deficient mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   748   C0684336:Impairment [Pathologic Function]

Phrase: "is"

Phrase: "ameliorated by infusion of recombinant apoE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0574032:Infusion [Therapeutic or Preventive Procedure]
   748   C1514798:recombinant [Organism]
   748   C1827465:Infusion [Functional Concept]
Processing 00000000.tx.277: Brain Res., 751, 307-314. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "751,"

Phrase: "307-314."
Processing 00000000.tx.278: MEDLINE Abstract 26. 

Phrase: "MEDLINE Abstract 26."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.279: Fagan, A.M., Bu, G., Sun, Y., Daugherty, A. and Holtzman, D.M. 

Phrase: "Fagan,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Y.,"

Phrase: "Daugherty,"

Phrase: "A."

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.280: (1996) Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Apolipoprotein E-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "high density lipoprotein"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0023821:High density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   827   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0178587:density [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "and"

Phrase: "is"

Phrase: "a ligand for the low density lipoprotein receptor-related protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1621296:receptor ligand [Molecular Function]
   739   C0023688:Ligand [Chemical]
Processing 00000000.tx.281: J. 

Phrase: "J."
Processing 00000000.tx.282: Biol. 

Phrase: "Biol."
Processing 00000000.tx.283: Chem., 271, 30121-30125. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "271,"

Phrase: "30121-30125."
Processing 00000000.tx.284: MEDLINE Abstract 27. 

Phrase: "MEDLINE Abstract 27."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.285: Simonet, W.S., Bucay, N., Pitas, R.E., Lauer, S.J. and Taylor, J.M. 

Phrase: "Simonet,"

Phrase: "W.S.,"

Phrase: "Bucay,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Pitas,"

Phrase: "R.E.,"

Phrase: "Lauer,"

Phrase: "S."

Phrase: "J."

Phrase: "and"

Phrase: "Taylor,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.286: (1991) Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Multiple tissue-specific elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013879:Elements [Element, Ion, or Isotope]
   779 E C1705248:Element [Conceptual Entity]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the apolipoprotein E/C-I gene locus in transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1708726:Gene Locus [Gene or Genome]
           Locus
Processing 00000000.tx.287: J. 

Phrase: "J."
Processing 00000000.tx.288: Biol. 

Phrase: "Biol."
Processing 00000000.tx.289: Chem., 266, 8651-8654. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "266,"

Phrase: "8651-8654."
Processing 00000000.tx.290: MEDLINE Abstract 28. 

Phrase: "MEDLINE Abstract 28."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.291: Roses, A.D. 

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.292: (1997) Apolipoprotein E, a gene with complex biological interactions in the aging brain. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Apolipoprotein E,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a gene with complex biological interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0079429:A Gene [Gene or Genome]
   767   C0596610:gene interaction [Genetic Function]
   753   C0017337:Gene [Gene or Genome]

Phrase: "in the aging brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.293: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.294: Dis., 4, 170-185. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "4,"

Phrase: "170-185."
Processing 00000000.tx.295: MEDLINE Abstract 29. 

Phrase: "MEDLINE Abstract 29."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.296: Tang, M.X., Stern, Y., Marder, K., Bell, K., Gurland, B., Lantigua, R., Andrews, H., Feng, L., Tucko, B. and Mayeux, R. 

Phrase: "Tang,"

Phrase: "M."

Phrase: "X.,"

Phrase: "Stern,"

Phrase: "Y.,"

Phrase: "Marder,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gurland,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lantigua,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Andrews,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Feng,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Tucko,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Mayeux,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.297: (1998) The APOE-[epsis]4 allele and the risk of Alzheimer Disease among African Americans, whites and Hispanics. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The APOE-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "the risk of Alzheimer Disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "among African Americans,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085756:African Americans [Population Group]
   861   C0027567:African [Population Group]
   861   C0596070:americans [Population Group]

Phrase: "whites"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007457:Whites [Population Group]
  1000   C0043157:Whites [Population Group]
   966 E C0220938:White [Qualitative Concept]

Phrase: "and"

Phrase: "Hispanics."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0086409:Hispanics [Population Group]
   966 E C0019576:Hispanic [Population Group]
Processing 00000000.tx.298: J. 

Phrase: "J."
Processing 00000000.tx.299: Am. 

Phrase: "Am."
Processing 00000000.tx.300: Med. 

Phrase: "Med."
Processing 00000000.tx.301: Assoc., 279, 751-755. 

Phrase: "Assoc.,"

Phrase: "279,"

Phrase: "751-755."
Processing 00000000.tx.302: 30. 

Phrase: "30."
Processing 00000000.tx.303: American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders. 

Phrase: "American Psychiatric Association"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0004083:Association [Mental Process]
   827   C0205487:Psychiatric [Functional Concept]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   755 E C0033872:Psychiatry [Professional or Occupational Group]
   755 E C0033873:Psychiatry [Biomedical Occupation or Discipline]

Phrase: "(1987"

Phrase: ")"

Phrase: "Diagnostic and statistical manual of mental disorders."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
  1000   C1136324:Diagnostic and Statistical Manual of Mental Disorders [Intellectual Product]
   877   C0599833:Diagnostic and Statistical Manual [Intellectual Product]
   818   C0004936:Mental disorders [Mental or Behavioral Dysfunction]
   795   C0011900:Diagnostic [Finding]
   795   C0012634:Disorders [Disease or Syndrome]
   795   C0024763:Manual [Intellectual Product,Manufactured Object]
   795   C0038215:Statistical [Occupation or Discipline]
   795   C0175674:Manual [Functional Concept]
   795   C0229992:mental [Mental Process]
   795   C0348026:Diagnostic [Functional Concept]
   785 E C0033975:mental disorder [Mental or Behavioral Dysfunction]
   768 E C0152097:diaphragm disorders [Disease or Syndrome]
   760 E C0277577:PSYCHIC DISORDER [Mental or Behavioral Dysfunction]
   712 E C0229993:Psychic [Functional Concept]
Processing 00000000.tx.304: Third edition revised (DSM-III-R), American Psychatric Association, Washington, DC. 

Phrase: "Third edition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441796:Third edition [Intellectual Product]
   861   C0441792:Edition [Intellectual Product]

Phrase: "revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "(DSM-III-R"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0220951:DSM III-R [Intellectual Product]
   901   C0444969:III/R [Intellectual Product]
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
   734   C0679229:DSM-III [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "American Psychatric Association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "Washington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:Washington [Geographic Area]

Phrase: "DC."
Processing 00000000.tx.305: 31. 

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.306: McKahn, G., Drachman, D., Folstein, M., Karzman, R., Price, D. and Stadlan, E. 

Phrase: "McKahn,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Drachman,"

Phrase: "D."

Phrase: ","

Phrase: "Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Karzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "and"

Phrase: "Stadlan,"

Phrase: "E."
Processing 00000000.tx.307: (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group Neurology, 34, 939-944. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRDA work group Neurology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0684224:Report [Intellectual Product]
   744   C0700287:Report [Health Care Activity]
   744   C3273238:Report [Intellectual Product]

Phrase: "34,"

Phrase: "939-944."
Processing 00000000.tx.308: 32. 

Phrase: "32."
Processing 00000000.tx.309: Hixon, J.E. and Vernier, D.T. 

Phrase: "Hixon,"

Phrase: "J.E."

Phrase: "and"

Phrase: "Vernier,"

Phrase: "D.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.310: (1991) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Restriction isotyping of human apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "by gene amplification"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017256:Gene Amplification [Genetic Function]
  1000   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   861   C0017337:Gene [Gene or Genome]
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]

Phrase: "and"

Phrase: "cleavage with HhaI."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]
Processing 00000000.tx.311: J. 

Phrase: "J."
Processing 00000000.tx.312: Lipid Res., 31, 545-548. 

Phrase: "Lipid Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "545-548."
Processing 00000000.tx.313: 33. 

Phrase: "33."
Processing 00000000.tx.314: Gilmour, R.S. and Dixon, G.H. 

Phrase: "Gilmour,"

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Dixon,"

Phrase: "G.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.315: (1972) Biosynthesis of protamine in trout testis. 

Phrase: "(1972"

Phrase: ")"

Phrase: "Biosynthesis of protamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005572:biosynthesis [Functional Concept]
   790   C0220781:Biosynthesis [Biologic Function]

Phrase: "in trout testis."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0039597:Testis [Body Part, Organ, or Organ Component]
   861   C1278981:Testis [Body Part, Organ, or Organ Component]
   777 E C0021358:Testes [Body Part, Organ, or Organ Component]
   768 E C0205070:Testicular [Spatial Concept]
   750 E C1284096:Testicle [Body Part, Organ, or Organ Component]
Processing 00000000.tx.316: J. 

Phrase: "J."
Processing 00000000.tx.317: Biol. 

Phrase: "Biol."
Processing 00000000.tx.318: Chem., 247, 4621-4627. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "247,"

Phrase: "4621-4627."
Processing 00000000.tx.319: MEDLINE Abstract *To whom correspondence should be addressed. 

Phrase: "MEDLINE Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0000857:Abstract [Occupational Activity]
   861   C0600678:Abstract [Intellectual Product]
   861   C1552863:Abstract [Idea or Concept]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.320: Tel: +33 3 20 87 72 28; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+33 3 20 87 72 28"

Phrase: ";"
Processing 00000000.tx.321: Fax: + 33 3 20 87 78 94; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+ 33 3 20 87 78 94"

Phrase: ";"
Processing 00000000.tx.322: Email: marie-christine.chartier{at}pasteur-lille.fr This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals Comments and feedback: www-admin{at}oup.co.uk Last modification: 12 Aug 1998 CopyrightOxford University Press, 1998.

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "marie-christine.chartier{at}pasteur-lille.fr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C2348513:Fr. [Conceptual Entity]
   795   C3538902:FR [Gene or Genome]

Phrase: "This page"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "is"

Phrase: "run by Oxford University Press,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035953:run [Daily or Recreational Activity]
   760   C0041740:University [Manufactured Object,Organization]
   760   C0600140:run [Finding]
   760   C1704688:Run [Functional Concept]
   760   C2346414:Run [Finding]

Phrase: "Great Clarendon Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "Oxford OX2 6DP,"

Phrase: "as"

Phrase: "part of the OUP Journals Comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "feedback"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015744:Feedback [Phenomenon or Process]
  1000   C2911691:Feedback [Mental Process]

Phrase: ":"

Phrase: "www-admin{at}oup.co.uk Last modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]

Phrase: ":"

Phrase: "12 Aug 1998 CopyrightOxford University Press,"

Phrase: "1998."

